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ABSTRACT 
 
Background Metabolic syndrome is a complex disorder that increases the risk of 
cardiovascular diseases. Metabolic syndrome has an unknown aetiology, but shifting 
dietary patterns such as increased consumption of industry-processed refined sugars 
have been implicated in the pathogenesis of the syndrome. Distributed along the length 
of the alimentary tract are macronutrient sensing mechanisms that play a key role in 
regulating feeding behaviour and energy balance and control intestinal nutrient-
transport capacity and the release of peptide hormones. Recent studies have suggested 
that the sweet-taste receptor, T1R2/3, senses small-intestinal glucose levels and co-
ordinates transport capacity and GLP1 release; however, the precise role of T1R2/3 in 
intestinal sugar sensing remains controversial. Studies have also suggested that 
macronutrient sensing is attenuated in diet-related metabolic disease; however, the 
mechanisms by which this occurs are not known. 
Aims We hypothesised that T1R2/3 expressed in enterocytes regulates intestinal sugar-
transport capacity. We also hypothesised that macronutrient sensors demonstrate a 
diurnal rhythm that is controlled by clock genes and that in obesity/diabetes the gene-
expression levels of such sensors are diminished.  
Methods To test our hypotheses we studied the expression levels of intestinal sugar 
sensors in nocturnal feeding rodents, rodents chronically fed a high-sucrose diet and 
Caco-2 cells — an enterocyte model. 
Results T1R2/3 gene expression was highest in the tongue, absent from the stomach 
and detected at low levels in the small intestine. SGLT3, a novel sugar sensor, was not 
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expressed in the tongue but was expressed in the stomach and small intestine.  A clear 
diurnal rhythm of clock genes CRY2 and BMAL1 was found in the tongue, stomach and 
small intestine. A diurnal rhythm for T1R2, T1R3 and the novel sugar sensor SGLT3 was 
detected in the stomach and small intestine, but not the tongue. SGLT3 expression, but 
not T1R2/3, was significantly decreased in mice fed a high-sucrose diet. SGLT3 and T1R3, 
but not T1R2, were detected in Caco-2 cells; however, we found no evidence of a 
functional sweet-taste receptor.   
Conclusion Taken together, these data suggest a novel interaction between intestinal 
clock genes and sugar-sensor mechanisms. Disturbances in clock gene/nutrient sensing 
interactions may be important in the development of diet-related diseases. T1R2/3 
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1 GENERAL INTRODUCTION 
1.1 Metabolic syndrome & the modern diet 
Metabolic syndrome is a major medical and economic challenge of modern 
society and is a disorder associated with a combination of metabolic abnormalities 
including obesity, hypertension, dyslipidaemia and insulin resistance and linked to 
cardiovascular diseases (Flegal et al., 2007). Increased dietary intake of carbohydrates 
and fat, dysregulated energy homeostasis, central obesity and reduced insulin sensitivity 
contribute to the metabolic derangements (Després & Lemieux, 2006). Why there has 
been such a continuous rise since the last century and the exact pathophysiological 
aetiology of metabolic syndrome are not clear. Obesity is one of the major risk factors 
for metabolic syndrome and has drastically increased from 13.3% in 1960-62 to 34.7% in 
2005-08 based on data from the National Health and Nutrition Examination Survey (Fig. 
1) (NHANES, 2012). 
 
Fig. 1 Increase in the percentage of people classed as obese (BMI ≥ 30.0) since the 1960s in the 
USA. Data from: (NHANES, 2012). 
The higher prevalence in obesity can only be explained by an increased energy 
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energy consumption has increased by approximately 425 kcal per capita since the 1970s 
in the US as estimated by the US Department of Agriculture (Fig. 2) (USDA, 2011). This 
dataset is based on food disappearance (corrected for waste), but other studies 
estimating daily food consumption using alternative methods produce very similar 
results (Swinburn et al., 2009; Duffey & Popkin, 2011)  
 
Fig. 2 Daily per capita calorie consumption since the 1970s based on food disappearance 
corrected for waste loss, based on data from the US Department of Agriculture. 
When the total energy intake is broken down into macronutrients it appears 
that the calories from protein have been stable over the last 40 years (Fig. 3). Although it 
seems that percent calories from fat decreased slightly, absolute amounts in grams have 
been stable. The energy surplus can hence be accounted for by a higher consumption of 
carbohydrates. On average the percentage of kcal from carbohydrates increased from 
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Fig. 3 Percentage of protein, fat and carbohydrates consumed daily in the US. Data are based on 
food disappearance corrected for waste loss supplied by the US Department of Agriculture 
(USDA, 2011). 
Carbohydrates are sourced from grains, fruit and vegetables in the form of 
simple sugars and starches or are added to foods as sugars. When the ‘carbohydrates’ 
group is broken down into its sources, it can be seen that not only the consumption of 
flour and cereal products in general, but also of caloric sweeteners, has increased (Fig. 
4).  
 
Fig. 4 Average daily calories obtained from flour and cereal products and caloric sweeteners. 
Together both account for ~40% of our daily energy intake. Data are based on food 
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Although corn is the major grain grown in the US, but most is fed to animals, 
hence the bulk of consumed carbohydrates is produced from grains, and especially 
wheat (USDA, 2011). 
The ‘caloric sweeteners’ can be broken down again and it demonstrates that 
refined sugar has been produced less from sugar cane and beet since the 1980s, but 
more from corn in the form of ‘High Fructose Corn Syrup’ (HFCS), dextrose and glucose 
(Fig. 5). HFCS gained a remarkable share of 50% over the years in the USDA data set. 
Natural sweeteners such as honey and edible syrups have not changed (Fig. 5).  
 
Fig. 5 Average daily calories obtained from caloric sweeteners broken down in its sources. Data 
are based on food disappearance corrected for waste loss on data by the US Department of 
Agriculture (USDA, 2011). 
Other US based studies estimate that 15% and 21.4% of energy intake for adults 
and adolescents respectively are ‘added sugars’ (Marriott et al., 2009; Welsh et al., 
2011). In Britain mean energy intake of ‘non-milk extrinsic sugars’ is currently 12% 
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amounts of added sugars has been hypothesised as a contributing factor to the rising 
rates of metabolic syndrome observed over the past few decades (Kaur, 2014).  
Although the USDA’s database gives a lot of information on the food use of the 
basic primary products (e.g. flour, eggs, potatoes etc.), little data exists on the 
processing and final product form. A study on beverage consumptions shows a move 
away from whole milk to either low-fat milk or sugar-sweetened beverages (SSB) 
(Popkin, 2010). A doubling in the consumption of soda and fruit drinks (and alcohol) 
between 1977 and 2006  was found, which indicates that more processed, highly 
palatable and rewarding foods, rich in mono- and di-saccharides and sweeteners, are 
being consumed (Popkin, 2010). SSBs are the main source of added sugars (Malik et al., 
2010), and associations of SSB consumption and weight gain, type 2 diabetes and 
cardiovascular disease have been found in several studies (Tordoff & Alleva, 1990; 
Berkey et al., 2004; Schulze et al., 2004; Bes-Rastrollo et al., 2006). 
Highly palatable, calorie dense food are highly rewarded in the hypothalamic 
and hindbrain nuclei, which is at the core of the inability to limit excessive food 
consumption, uncontrolled weight gain and the onset of metabolic syndrome (Cordain 
et al., 2005; Lenoir et al., 2007; Volkow et al., 2011). From an evolutionary perspective 
this behaviour is advantageous as it ensures that nutrients are consumed when available 
and energy is stored as fat to increase survival in times of scarcity. However, in our 
modern world where food is widely available and designed to be highly rewarding, this 
adaptation has become a problem. 
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1.2 Metabolism & the gut-brain axis 
The brain centrally coordinates energy intake and expenditure by directly 
sensing nutrient levels (glucose, amino acids and fatty acids) and by integrating 
messages from all peripheral tissues including adipose, liver, muscle, pancreas and 
gastrointestinal tissues (Badman & Flier, 2005; Guyenet & Schwartz, 2012). The 
hypothalamus is able to regulate food intake, physical activity, basal metabolic rate and 
endocrine systems by integrating the long-term energy status via leptin from adipose 
tissue and insulin via the pancreas and also recent nutrient intake via signals from the 
gut.  
The alimentary tract is responsible for the digestion and absorption of foods 
and assimilation of nutrients. There are anticipatory physiological responses to feeding, 
the cephalic phase responses, that set in motion an array of digestive and signalling 
cascades (neuronal & endocrine). This preparatory adaptation not only increases the 
efficiency of digestion, absorption and metabolisation of nutrients but also directly and 
indirectly regulates meal size and duration of eating. 
1.2.1 Gut peptides 
Pre-digested food from the mouth is transported via the oesophagus to the 
gastrointestinal tract. The stomach and intestine are the main sites of digestion and 
nutrient uptake and a highly developed organ with autonomous nervous and immune 
systems. The gut delivers messages about the nutritional status to the brain through 
afferent nerves and the vagus nerve system, but also via endocrine pathways. 
Throughout the gastrointestinal tract highly specialised endocrine cells are found 
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between the parenchymal cells secreting more than twenty gut hormones and the gut is 
considered the ‘largest endocrine organ in the body’ (Ahlman & Nilsson, 2001).  
Ghrelin is a gut hormone produced in the stomach. Levels peak before meal 
ingestion and fall to a minimum within one hour of eating. It is thought that ghrelin 
serves as a signal to start eating. It has been suggested the gastric taste cells sense food 
load in the stomach and suppress ghrelin production which protects from overeating 
and overfilling of the stomach (Hass et al., 2010). A strong argument for the sensing 
capabilities is that the degree of ghrelin suppression depends on the type of nutrient 
consumed, with proteins and carbohydrates being more suppressive than lipids (Foster-
Schubert et al., 2008). 
The small intestine has a variety of cell types involved in chemosensation and 
hormone secretion. Intestinal enteroendocrine cells (EECs) appear long and narrow with 
their apical membrane and microvilli projecting to the lumen. In response to meal 
ingestion I-cells secrete the gut hormone cholecystokinin (CCK), K-cells glucose-
dependent insulinotropic polypeptide (GIP) and L-cells the peptides glucagon-like 
peptide-1 and 2 (GLP1 & 2) and peptide tyrosine tyrosine (PYY) (Young, 2011b). These 
gut hormones have been found to be important in regulating food intake and functions 
in whole body metabolism. While ghrelin stimulates food intake, CCK from the small 
intestine inhibits eating, slows gastric emptying, mediates intestinal motility and 
stimulates pancreatic and gall-bladder secretions. In response to intraluminal chyme, 
plasma CCK levels rise and peak within minutes of eating, remain elevated throughout 
feeding and decline to baseline levels by the time the meal is terminated (Liddle et al., 
1985).  
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PYY and GLP1 levels rise immediately after food intake, but peak after meal 
ingestion (Wen et al., 1995). Both gut peptides also inhibit eating, although GLP1 
degrades very rapidly due to the activity of dipeptyl-peptidase IV (DPPIV). PYY and GLP1 
decrease gastric motility, but also slow pancreatic secretions into the small intestine, 
which delays digestion and slows nutrient absorption, maintaining satiety. Furthermore, 
GLP1 increases insulin secretion, but inhibits glucagon production in the pancreas, 
facilitating the disposal of ingested nutrients and the lowering of blood glucose levels 
(Ahrén et al., 1995). GIP likewise leads to glucose-dependent insulin secretion, but also 
promotes energy storage in adipose tissue and bone formation. The gut peptides’ insulin 
stimulatory effects are termed ‘incretin response’ (Drucker, 2006). It has been shown 
that the incretin response is mediated not only via endocrine pathways, but also via 
neuronal pathways. Vagotomy blunts the incretin response to fat stimulus (Rocca & 
Brubaker, 1999), but exact mechanisms are still unclear.  
1.2.2 Nutrient sensing in the alimentary tract 
The molecular identity of nutrient sensor mechanisms has emerged over the 
last 15 years (Hoon et al., 1999; Chaudhari & Roper, 2010). The mouth and tongue is the 
first entity in contact with food where lingual sensors detect the basic tastes sweet, 
salty, bitter, fat, sour, umami and possibly a few others. Tasting helps in finding not only 
energy- and nutrient-rich but also toxin-free food sources. Furthermore, it has been 
suggested that lingual tasting primes the gastrointestinal tract to digestion and nutrient 
absorption to maximise macro- and micronutrient intake ultimately leading to an 
increased chance of survival (Butterworth et al., 2011). Mammals have evolved a host of 
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nutrient sensors that are conserved between species, of a transmembrane nature and 
specific for each taste quality.  
There are three distinct taste cells In the oral cavity, which are nested in onion-
like structures in the various taste papillae (Calvo & Egan, 2015). Type-II cells are 
receptor cells equipped with sensors for sweet, umami and bitter taste. Type-III cells are 
presynaptic cells, potentially involved in ‘sour’ tasting, but especially important as a 
connector for Type-II cells, forming synapses with nerves. Receptor cells activated by 
sweet, bitter and umami compounds are induced to release adenosine triphosphate 
(ATP) through pannexin1 (PANX1) hemi-channels. The extracellular ATP excites ATP 
receptors (P2X, P2Y) on sensory nerve fibres and on Type-III cells which leads to 
neurotransmitter release and signal transduction to the brain. Type-I cells are potentially 
involved in ‘salty’ sensing, but also appear to be involved in terminating synaptic 
transmission and restricting the spread of transmitters (Chaudhari & Roper, 2010) 
Distinct receptors for each taste quality can be found on the aforementioned 
taste cells (Chaudhari & Roper, 2010). The sweet-taste receptor is made up of a 
heterodimer of T1R2 and T1R3 and is stimulated by a wide variety of sugars, but also by 
artificial sweeteners of a chemically varied  nature. Umami, the taste of L-glutamate and 
a few other L-amino acids, is mediated via a heterodimer of T1R1 and T1R3, but 
metabotropic glutamate receptors have also been implicated (Chaudhari et al., 2000). 
Bitter chemicals are sensed by a large number of taste sensors in the T2R family. The 
saltiness of Na+ is detected by direct permeation of Na+ ions through membrane ion 
channels such as the epithelial Na channel (ENaC) to depolarise the membrane (Lin & 
Finger, 1999). Sour taste mediated by protons excites presynaptic cells, but the 
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molecular identity of the sensor is not clear (Tomchik & Berg, 2007). Triglycerides can be 
rapidly hydrolysed in the oral cavity and free fatty acids can be sensed by several 
sensors, including CD36, GPR40 and GPR120 (Laugerette et al., 2005; Wellendorph et al., 
2009).  
A landmark finding was that sweet-, umami-, fat- and bitter-taste receptors are 
not restricted to the tongue, but can also be found throughout the body, including the 
pancreas, stomach and small intestine (Dyer et al., 2005; Bezençon et al., 2007; Mace, 
Affleck, et al., 2007). In the stomach mucosal cells for chemosensation and ghrelin 
production have been found to express T1R3 and αGustducin (Hofer et al., 1996; Hass et 
al., 2010). Like ghrelin producing cells in the stomach, EECs express a variety of taste 
receptors and the necessary signalling molecules (reviewed in Janssen & Depoortere, 
2013). A proposed model of gastrointestinal nutrient sensor mechanisms is shown in Fig. 
6.  
 
Fig. 6 Model of components involved in gastrointestinal nutrient sensing. Nutrients are sensed 
by luminal GPCRs or transporters in several cell types in the mucosa (EECs, enterocytes and brush 
Chapter 1: General introduction 
 
- 28 - 
cells) which in turn can affect each other’s expression. Second-messenger release induced by 
sensors can lead to the release of basolateral gut peptides which can then affect metabolism via 
the blood-stream or stimulate vagal afferents. Figure adapted from Janssen & Depoortere, 2013. 
Luminal nutrients can be sensed by taste receptors and transporters on EECs 
(Gerspach et al., 2011; Steinert et al., 2011). The luminal nutrient-receptors are 
connected to the intracellular second-messenger machinery via αGustducin. This can 
lead to either the release of gut peptides or to membrane depolarisation via basolateral 
ion channels such as the Transient receptor potential cation channel subfamily M 
member 5 (TRPM5). This enables the tissue to adapt to the nutrient composition of the 
chyme and also regulates metabolism in the body. Gut peptides have effects on the 
brain and metabolic tissues in the periphery (pancreas, adipose tissue, liver) directly via 
endocrine pathways or indirectly via neuronal pathways.  
Recent studies have revealed that the ‘classic’ gut peptides are also expressed 
in taste cells on the tongue (reviewed in Dotson et al., 2013). Genetic and 
pharmacological experiments indicate a critical role for lingual gut peptides in the 
modulation of taste responsiveness and preferences. Mostly auto- or paracrine function 
have been assigned to these tongue-expressed peptides, as the hormones and their 
respective receptors are expressed on the same or neighbouring cells such as nerve 
fibres (Dotson et al., 2013). Yet it has also been shown that GLP1 is secreted into the 
circulation within minutes of the application of glucose to the tongue (Kokrashvili et al., 
2014). This data suggests that the involvement of lingual taste sensing and peptide-
hormone release is important for the cephalic phase of digestion and potential feed-
forward mechanisms to the gastrointestinal tract in order to prepare the distal digestive 
tract. 
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Yet it has also been shown how hormones such as leptin and gastrointestinal 
gut peptides change the responsiveness of lingual chemosensory cells to taste stimuli 
(Nakamura et al., 2008). Indeed, it has been suggested that changes in the levels of 
circulating hormones mediate the changes in taste perception observed after gastric 
bypass surgery (Hajnal & Kovacs, 2010; Miras & Roux, 2010; Bueter et al., 2011). These 
findings implicate a feed-backward loop from the gastrointestinal tract up to the oral 
cavity and brain to regulate food intake. 
  
Chapter 1: General introduction 
 
- 30 - 
1.3 Expression of sugar transporters and sensors in the 
alimentary tract 
The goal of this thesis is to study nutrient sensor mechanisms in health and 
disease. In order to do this it is important to know the spatial expression of such 
sensors. We therefore analysed the cephalocaudal expression of sugar transporters and 
nutrient sensors along the alimentary tract of mice. 
1.3.1 Expression of sugar transporters in the gastrointestinal tract 
We evaluated our system by analysing the gene expression of known hexose 
transporters (SGLT1, GLUT2 and GLUT5) along the small intestine. 15 mg of small-
intestinal tissues from eight six-week-old CD-1 mice were dissected, RNA extracted and 
cDNA transcribed for subsequent RT-qPCR (methods outlined in 3.4). Exact locations 
(proximal or distal) is not known and whole tissues including the serosa, muscularis 
propria, submucosa and the three layers of the mucosa. Consistent with previous 
reports (Yoshikawa et al., 2011), mRNA expression of slc5a1 (SGLT1), slc2a2 (GLUT2) and 
slc2a5 (GLUT5) is highest in the proximal regions, duodenum and jejunum, but is lower 
in the ileum (Fig. 7). This matches the higher luminal concentration of sugars in the 
duodenum and jejunum.  
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Fig. 7 mRNA expression of hexose transporters in the small intestine of adult mice. Whole 
duodenal, jejunal or ileal tissue was dissected from six-week old CD-1 mice (n=8) for subsequent 
quantitative PCR of slc5a1 (SGLT1), slc2a2 (GLUT2) and slc2a5 (GLUT5). Values are normalised 
against three reference genes and relative quantitation is performed using the ddCT method and 
expressed relative to duodenum.  
 
1.3.2 Expression of the sweet-taste machinery in the alimentary tract 
In addition to the hexose transporters we evaluated the gene expression of 
nutrient sensors along the murine alimentary tract including tongue, stomach and small 
intestine. As demonstrated in Fig. 8, the umami- and sweet-taste receptor molecules 
tas1r1 (T1R1), tas1r2 (T1R2) and tas1r3 (T1R3) and downstream signalling molecules 
gnat3 (αGustducin) and gnat1 (αTransducin) are all highly expressed in the tongue, 
where they have been described first (Hoon et al., 1999). 
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Fig. 8 mRNA expression of nutrient sensor genes in the small intestine of adult mice. Whole 
tongue, stomach, duodenum, jejunum and ileum was dissected from six-week old CD-1 mice 
(n=8) for subsequent quantitative PCR of tas1r1 (T1R1), tas1r2 (T1R2), tas1r3 (T1R3), gnat3 
(αGustducin) and gnat1 (αTransducin). Values are normalised against 3 reference genes and 
relative quantitation is performed using the ddCT method and expressed relative to duodenum. 
ND = not detected. 
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T1R1 and T1R2 are not expressed in the stomach, but T1R3 is. Interestingly, we 
detected high expression levels of αGustducin and αTransducin in gastric tissues, with 
~4x and ~20x higher expression than in lingual extracts. Contrary to data published on 
humans we were not able to show expression of T1R1 and T1R2 in the stomach, but 
showed T1R3 mRNA levels (Bezençon et al., 2007). Another study confirms our findings 
with no expression of T1R2, but expression of T1R3 (Young et al., 2009). This study also 
dissected the expression between fundus, corpus and pylorus and showed higher 
expression in fundus and corpus and lower expression in antrum. Further discrepancies 
appear comparing αGustducin expression in stomach. Bezençon et al., 2007 were not 
able to detect αGustducin in stomach, whereas other studies (Hofer et al., 1996; Young 
et al., 2009) and our own experiments show gastric expression. αGustducin in the 
stomach has been suggested to be involved in L-glutamate sensing via mGluR1 (San 
Gabriel et al., 2007), which has been associated with increased protease secretion 
necessary for the gastric phase of protein digestion (Vasilevskaia et al., 1993). Similarly, 
gastric αGustducin is also involved in the control of bitter sensor mediated ghrelin 
release, resulting in delayed gastric emptying and stimulated food intake (Janssen et al., 
2011). Regarding sweet-taste sensation, the expression of T1R2 is rather 
low/undetectable, thus rendering the formation of a T1R2/3 heterodimer unlikely. T1R3 
has been suggested to works on its own as a homodimer to detect sweet compounds 
(Nelson et al., 2001; Zhao et al., 2003). It is possible that T1R3 could also dimerise with a 
yet unknown partner or a completely different sensor, as we expect, similar to the other 
nutrients, a gastric phase of chemosensation necessary for feed-forward mechanisms 
and signalling to the brain. 
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T1R1, 2 and 3, αGustducin and αTransducin are expressed in the small intestine, 
although at ~5 - 45x lower levels than in the tongue (Fig. 8). A similar trend regarding the 
expression levels from proximal to distal can be observed with higher levels in the 
duodenum and jejunum than in the ileum (Fig. 8). αTransducin was not even detected in 
the ileal samples. Taste receptors followed a similar pattern to the hexose transporters, 
with higher expression in the proximal regions. This suggests that T1R1/3 and T1R2/3 via 
αGustducin/αTransducin are involved in proximal nutrient detection. This so called 
‘duodenal brake’ is important to inhibit gastric emptying and acid secretion (Rønnestad 
et al., 2014) 
1.3.3 Expression of the novel sugar sensor SGLT3 in the alimentary tract  
SGLT3 has been suggest to be a sugar sensor rather than a transporter 
(Barcelona et al., 2012). SGLT3/slc5a4 belongs to the same family as SGLT1/slc5a1. 
Despite a 76% genetic identity match of SGLT1 and SGLT3  in humans (NCBI blast), SGLT3 
does not transport D-Glu, but results in Na+- and Phloridzin (PZ)-sensitive depolarisation 
(Diez-Sampedro et al., 2003). While in humans only one gene codes for SGLT3, a gene-
duplication has occurred in mice and rats. Human SGLT3 has 82% mRNA sequence 
identity with murine SGLT3a and SGLT3b. Murine SGLT3a and SGLT3b have 80% mRNA 
and 75% amino acid sequence identity (NCBI blast). SGLT3a is similar in its properties to 
human SGLT3 (high D-Glu affinity, no transport). SGLT3b is more similar to SGLT1, 
showing D-Glu transport, but at a lower capacity. Yet the exact role of SGLT3(a+b) is not 
fully understood. A detailed distribution and comparative intensities of expression of the 
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SGLT3s along the alimentary tract has not been demonstrated and could improve the 
functional interpretation of these proteins. 
We therefore analysed, for the first time, the cephalocaudal axis of gene 
expression for SGLT3 in the alimentary tract. Our analysis revealed that in the tongue 
neither slc5a4a (SGLT3a) nor slc5a4b (SGLT3b) is expressed (Fig. 9), which suggests that 
it is not involved in sweet-taste perception on the tongue.  
In the stomach slc5a4b (SGLT3b), but not slc5a4a (SGLT3a) is expressed at the 
mRNA level, although at 20-fold lower levels than in the small intestine where both 
genes are expressed. SGLT3a follows the pattern of luminal sugar concentrations like the 
hexose transporters, with higher expression proximally. SGLT3b shows its highest 
expression in the ileum (Fig. 9). 










































































































Fig. 9 mRNA expression of SGLT3 in the murine alimentary tract. Whole tongue, stomach, 
duodenum, jejunum and ileum was dissected from six-week old CD-1 mice (n=8) for subsequent 
quantitative PCR of slc5a4a (SGLT3a), slc5a4b (SGLT3b) and slc2a5 (GLUT5). Values are 
normalised against 3 reference genes and relative quantitation is performed using the ddCT 
method and expressed relative to duodenum. ND = not detected. 
SGLT3 is expressed in cholinergic neurons of the enteric nervous system and 
skeletal muscle where it is thought to regulate smooth and skeletal muscle activity (Diez-
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Sampedro et al., 2003). Furthermore, SGLT3 has been shown to be expressed in the 
hypothalamus, spleen, kidney, liver, portal vein and intestinal mucosa (Kong et al., 1993; 
Gribble et al., 2003a; O’Malley et al., 2006; Kothinti et al., 2012; Delaere et al., 2013). 
Experimental research has shown that SGLT3 is involved in D-Glu sensing in the 
hypothalamus (O’Malley et al., 2006), portal vein (Delaere et al., 2013), kidney (Kothinti 
et al., 2012) and GLP1 secreting L-cells (Gribble et al., 2003a; Lee et al., 2015). Despite 
these findings, the exact roles of SGLT3a+b are not well established. 
Both genes have different expression patterns, which suggests that both genes 
are regulated differently on the transcriptional/post-transcriptional level. This also 
suggests different functional roles for both genes/proteins.  
SGLT3a has no known transport function, and it has been suggested that it 
works as a glucose sensor. GLP1 plasma levels rise rapidly after nutrient ingestion and 
the enteric nervous system has been found to be important for the proximal-distal loop 
regulating GLP1 release from the L-cells of the distal small intestine (Rocca & Brubaker, 
1999). SGLT3a could be involved in assessing luminal or absorbed sugar D-Glu 
concentrations, strategically expressed in the mucosa or on cholinergic neurons. We 
speculate that SGLT3a is involved in the proximal-distal loop for the secretion of GLP1. 
SGLT3b on the other hand is highly expressed in the distal regions of the small 
intestine, but also in the stomach. The strategic expression in the stomach might be 
important for ghrelin release, as well as the proximal-to-distal loop to signal to the 
ileum.  This is important as the ileum is the small-intestinal region with the highest 
density of GLP1-secreting L-cells (Tolhurst et al., 2009) and GLP1 is central to regulating 
Insulin secretion and other core metabolic pathways. SGLT3 is potentially involved in 
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GLP1 secretion as experiments in an L-cell model, GLUTag cells, have shown (Gribble et 
al., 2003b). Indeed, very recent data using an SGLT3 inhibitor directly links SGLT3 sensing 
with GLP1 secretion (Lee et al., 2015). We speculate that SGLT3b is a high-affinity D-Glu 
transporter in the distal small intestine involved in the ileal brake phenomenon. 
Feedback mechanism like these are important not only to provide information to the 
central brain regions involved in satiety and feeding behaviour, but also to help 
digestion and nutrient assimilation by slowing gastrointestinal motility, inducing 
enzyme, gut peptide secretion and by regulating transport mechanisms. Overstimulation 
by dietary sugars can make such systems signal resistant, which can then become 
over/under active and lead to metabolic dysregulations. 
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1.4 Nutrient sensor mechanisms as targets for metabolic 
syndrome 
Analogues for satiety hormones like GLP1 agonists are already used in the clinic 
(Tella & Rendell, 2015), but directly targeting nutrient sensors to stimulate/block gut 
peptide secretion could present an alternative and more holistic approach, as the 
various chemosensors are present on the many different EECs and would lead to a 
broader regulation of gut peptide secretion. New targets offer novel approaches for the 
prevention or treatment of metabolic syndrome. Most progress has been made in the 
development of free fatty-acid receptor (FFAR) agonists to treat type 2 diabetes. 
Targeting FFAR2 led to increased GLP1 and PYY levels, which resulted in a reduction of 
non-alcoholic fatty-liver disease (Chambers et al., 2015). The sweet-taste receptor, 
specifically T1R3, has also been studied as a target to control body weight and a patent 
has been submitted to protect the use of this method (Shirazi-Beechey & Iserentant, 
2009). Data of marmoset monkeys on an obesogenic diet for 11 weeks treated with the 
T1R3 inhibitor Lactisole are presented in this patent. While the control animals became 
obese and doubled their body weight, animals with Lactisole treatment were able to 
stay on a level comparable to lean controls. A more recent human study was able to 
show that Lactisole, a T1R3 antagonist, blocked GLP1 and PYY secretion successfully 
(Steinert et al., 2011). 
Despite recent advances, major questions remain regarding the role of nutrient 
sensors in the regulation of intestinal function in health and disease.  
Luminal sugar levels regulate sugar-transport capacities in enterocytes (Ferraris 
& Diamond, 1989). Yet precise mechanisms of how sugar transporters are regulated in 
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the short and long term are less understood. It has been suggested that sugar is directly 
sensed by T1R2/3 expressed on enterocytes to regulate sugar-transport capacities in the 
short term (Kellett et al., 2008). Yet it has also been suggested that neighbouring EECs 
regulate sugar transport in enterocytes via paracrine effects of secreted gut peptides 
(Margolskee et al., 2007). Exact mechanisms and pathways are not clearly established. 
The role of nutrient sensing mechanisms in metabolic diseases is an active area 
of research. Evidence in humans and rodents suggests dysregulation off EECs in 
metabolic syndrome. It has been shown that obesity and type 2 diabetes can blunt the 
incretin response (Nauck et al., 1986). In addition,  gustatory and ghrelin-producing cells 
were found to be more numerous in obese patients (Widmayer et al., 2012). Similar 
findings were found in an obese high-fat-fed mouse model, where the numbers of 
GPR120 expressing brush cells as well as gastrin- and ghrelin-producing cells were 
increased (Widmayer et al., 2015).  Yet reports of dysregulations of nutrient sensors by 
dietary factors, especially a high-sucrose diet, are scarce and not well studied (Young et 
al., 2009; Widmayer et al., 2012; Widmayer et al., 2015). 
Disruptions in clock genes have been linked to metabolic disease, but exact 
mechanisms are unclear. Intestinal processes are regulated not only in response to 
luminal concentrations, but mammals have developed anticipatory, circadian 
mechanisms to optimise energy and nutrient uptake. The sugar transporter SGLT1 is 
regulated in a diurnal fashion and is under the control of clock genes (Corpe & Burant, 
1996; Balakrishnan et al., 2012). Furthermore, GLP1 has been shown very recently to 
display diurnal rhythmicity (Gil-Lozano et al., 2014). Yet the rhythmicity of sensor 
mechanisms has not been studied under healthy or diseased conditions. 
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It is therefore important to better understand how nutrient sensors influence 
transport activity, how their expression is spatially and temporally regulated and how 
they are affected in metabolic diseases. This will pave the way to finding new targets to 
prevent or treat metabolic syndrome. 
1.5 Aims, hypotheses & rationale 
Aims of the study  
 Specific aim 1: Study the short-term regulation of sugar transport via the 
sweet-taste receptor T1R2/3 in enterocytes in an in vitro model. 
 Specific aim 2: Evaluate diurnal rhythmicity of nutrient sensor expression 
along the murine alimentary tract. 
 Specific aim 3: Examine nutrient sensor gene expression under diabetic 
conditions. 
Hypotheses 
 The sweet-taste receptor T1R2/3 is expressed on enterocytes and is able 
to directly influence transport capacities of the cell. 
 Mice show diurnal rhythms of gastrointestinal nutrient sensors 
anticipatory to nocturnal feeding. 
 A chronic diet high in sucrose leads to type 2 diabetes mellitus and 
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Rationale 
We used an in vitro enterocyte model, Caco-2 cells, a human colon cancer cell line that 
appears enterocyte-like upon culture. These cells express the hexose transporters 
SGLT1, GLUT2 and GLUT5 (Mahraoui et al., 1994), but also the sweet-taste receptor 
T1R2/T1R3 (Le Gall et al., 2007). 
We used mouse models for in vivo studies, as mice have the same conserved core clock 
machinery found in all mammals (Reppert & Weaver, 2001) and have also been widely 
used for researching gastrointestinal function, as mice express all the common nutrient 
transporters and sensors found in humans. 
To study gastrointestinal dysregulations in type 2 diabetes we fed mice for six weeks on 
a test diet of chow plus free access to light condensed milk, to emulate a diet rich in 
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CHAPTER 2  
SHORT-TERM REGULATION OF SUGAR TRANSPORT 
IN AN IN VITRO MODEL OF ENTEROCYTES  —   
CACO-2/TC7 CELLS  
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2 SHORT-TERM REGULATION OF SUGAR TRANSPORT IN AN IN VITRO 
MODEL OF ENTEROCYTES — CACO-2/TC7 CELLS 
2.1 Summary 
Background The gastrointestinal tract plays a key role in regulating nutrient metabolism 
and energy balance; the response of the gastrointestinal tract to ingested carbohydrates 
is therefore an active area of research. The molecular mechanisms by which dietary 
carbohydrates regulate intestinal sugar transport are controversial. Two models 
currently exist both involving the sweet-taste receptors T1R2/3: an indirect model, 
whereby T1R2/3 expressed on mucosal EECs is activated by luminal carbohydrates, 
resulting in the release of gut peptides, which in turn regulate the enterocytes, and a 
direct model, whereby T1R2/3 is expressed on the enterocyte and directly regulates 
enterocyte function.  
Aims We hypothesised that the sweet-taste receptor T1R2/3 is expressed on 
enterocytes and directly regulates sugar-transport capacities in enterocytes upon 
stimulation by sugars and artificial sweeteners. 
Methods To study the direct model we used the Caco-2/TC7 cell line, a well-established 
in vitro model of the human enterocyte. Uptake of D-Glu and Fru into Caco-2/TC7 cells 
was assessed using radiolabelled sugars and expression of the intestinal sugar 
transporters and sweet-taste receptors was determined by RT-PCR. Regulation of sugar 
transport by T1R2/3 was assessed using agonists in the form of mono- and 
disaccharides, artificial sweeteners or the inhibitor Lactisole. 
Results Carrier-mediated D-Glu and Fru uptake by SGLT1 and GLUTs was detected in 
Caco-2/TC7 cells. Increasing concentrations of D-Glu or HFCS in the media resulted in a 
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4-fold increase in D-Glu uptake, but was not blocked by Lactisole or enhanced by 
artificial sweeteners. RT-PCR revealed only T1R3 (but not T1R2) expression in Caco-
2/TC7 cells. Fru or sucrose had no effect on D-Glu or Fru uptake. 
Conclusions Our in vitro data suggest that the sweet-taste receptor is not responsible 
for the detected direct regulation of intestinal D-Glu/Fru transport. Potentially another 
sensor is involved in sugar sensing, but control by neighbouring EECs cannot be 
excluded. Furthermore, the Caco-2/TC7 cell model may not be an appropriate model to 
study direct regulation of sugar transport by T1R2/3. 
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2.2 Background 
The gastrointestinal tract is the site of nutrient digestion and uptake. Nutrient 
assimilation is not a passive process; mechanisms exist that tightly regulate transport 
capacities to match luminal nutrient load. Chronic/long-term mechanisms, as well as 
acute/short-term mechanisms exist to control nutrient uptake following their ingestion. 
The breakdown of macronutrients, including carbohydrates, is facilitated by several 
enzymes that are secreted from the exocrine pancreas and liver or are present on the 
microvillus brush border surface (e.g. lactase, Sucrase-Isomaltase) of the enterocytes. 
Once carbohydrates are hydrolysed into monosaccharides they can be transported 
across the enterocyte into the portal circulation. 
Dietary D-Glu is transported across the apical membrane of the enterocyte by 
the Sodium/glucose co-transporter SGLT1 and Fru is transported by the facilitative 
transporter GLUT5. D-Glu and Fru then exit the enterocyte via basolateral GLUT2 into 
the bloodstream. SGLT1 has a high affinity, but a low capacity for D-Glu, saturating at a 
concentration of 30–50 mM (Debnam & Levin, 1975) and  can be inhibited by Phloridzin 
(Donhoffer, 1935). Yet the intestinal transport capacity is linear up to luminal D-Glu 
concentration of several hundred millimolar (Holdsworth & Dawson, 1964). These 
observations indicate the presence of a second transport component described as 
Phloridzin-insensitive and ‘diffusive’ or ‘passive’, as it is linear and non-saturable 
(Debnam & Levin, 1975). This secondary component accounted for 75% of D-Glucose 
absorption and was hypothesised to be mediated through a paracellular flow 
mechanism (Madara & Pappenheimer, 1987; Pappenheimer & Reiss, 1987). It was 
observed that high amounts of water were absorbed and it was proposed that SGLT1 
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activity leads to the contraction of the perijunctional actomyosin ring (Turner et al., 
1997). This contraction then dilated the intercellular tight junctions, facilitating the 
osmotically driven flow of D-Glu through the paracellular solvent drag. This theory was 
disproved in several studies (Lane et al., 1999; Ferraris & Diamond, 1997; Schwartz et 
al., 1995) who showed that paracellular D-Glu flow accounted only for 2–7% over a 2 h 
period in dogs. Furthermore, it had already been shown by Debnam & Levin in 1975 that 
the facilitative component did not rely on SGLT1 activity, as D-Glu was still readily 
absorbed after blocking active transport by Phloridzin.  
A large body of research has been conducted since, leading to a new dogma for 
the facilitative component: GLUT2 insertion into the apical membrane. Functional 
studies revealed that D-Glu transport in normal rat jejunum was mediated mainly by 
SGLT1 at low luminal concentrations (~10 mM D-Glu), but that GLUT2 was responsible 
for up to 75% of D-Glu transport if the concentrations was raised to 100 mM (see Fig. 
10) (Kellett & Helliwell 2000). 
 
 
Fig. 10 Acute short-term D-Glu absorption in the perfused rat jejunum. Left panel: D-Glucose 
transport was dissected into two components, a Phloretin-sensitive GLUT2 component and a 
Phloretin-insensitive SGLT1-mediated component. Right panel: protein levels of apical SGLT1 and 
GLUT2 showing that GLUT2 insertion increases with the D-Glucose concentration while SGLT1 
stays stable. (Figure reproduced from Kellett et al., 2008). 
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The transient insertion of GLUT2 into the apical membrane is very rapid (t1/2 
~3.5 min) and correlated with an activation of protein kinase C (PKC) isoform βII 
(Helliwell et al., 2000). Several studies have since confirmed the apical location of GLUT2 
(Au et al., 2002; Affleck et al., 2003; Gouyon et al., 2003; Grefner et al., 2006; Tobin et 
al., 2008). 
In 2007 the Kellett group proposed in two papers that apical GLUT2 is reliant on 
intracellular Ca2+ levels mediated by the L-type channel Cav1.3 (Mace, Morgan, et al., 
2007; Morgan et al., 2007), since PKC βII activity is Ca2+ dependent (Hug & Sarre, 1993), 
Ca2+ is necessary for cytoskeletal rearrangements (Madara & Pappenheimer, 1987; 
Turner, 2000) and D-Glu itself is depolarising. 
The Kellett model appears to be the established model for intestinal sugar 
transport (summarised in Fig. 11), but remains controversial.  
 
Fig. 11 Proposed mechanisms of monosaccharide absorption in the small intestine. A: SGLT1 
transports D-Glu of levels of up to 30 mM. SGLT1 is an active transporter driven by a Na+ gradient 
created by the basolateral Na+/K+ ATPase. There is low or no apical GLUT2. B: After a meal, when 
higher concentrations of luminal D-Glu are present, GLUT2 is rapidly inserted into the apical 
membrane as mediated by the depolarising effect of Na+, which in turn activates the calcium 
transporter Cav1.3. Ca2+ ions are necessary for the cytoskeletal rearrangements and PKCβII 
activity is necessary for the insertion of GLUT2 into the apical membrane. (Figure reproduced 
from Kellett & Brot-Laroche, 2005). 
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An SGLT1 knockout model revealed that GLUT2 insertion is SGLT1 dependent 
(Gorboulev et al., 2012). Yet this same study led to a discussion that GLUT2 is 
responsible for less than 10% of D-Glu transport in the control mice. Consistent with this 
observation, it was found in a study of human glucose-galactose malabsorption that this 
is due to SGLT1 mutations, resulting in a non-functional protein (Martín et al., 1996). 
Another set of studies also challenged the Kellett model (Stümpel et al., 2001; 
Santer et al., 2003). GLUT2 knockout mice and GLUT2-deficient patients show no signs 
of glucose-galactose malabsorption. It was suggested that D-Glu exit from the 
enterocyte into the plasma appeared by phosphorylation, transfer into the 
endoplasmatic reticulum and vesicular exocytosis from the basolateral membrane. For 
how much transport capacity this alternative mechanism accounts is not clear, but it 
was estimated to be approximately 15% (Kellett et al., 2008). 
A refined role of apical GLUT2 has been suggested recently (Naftalin, 2014). 
GLUT2 could act as an apical osmoregulator to protect the cell from damage from cell-
volume change upon increased intracellular D-Glu rather than as a D-Glu transporter, 
but this view has been highly contested (see review reports of publication for a detailed 
discussion). 
As explained previously, Ca2+ ions play an important role in the regulation of 
apical GLUT2 trafficking, but it has been argued that a second signal is necessary for 
mass D-Glu absorption. A landmark finding was that taste receptors for bitter (T2R 
family), umami (T1R1/3) and sweet (T1R2/3) and the necessary downstream signal-
transduction machinery, including αGustducin, first described in lingual taste buds, can 
also be found throughout the gut (reviewed in Iwatsuki & Uneyama, 2012).  
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Kellett and colleagues suggested that the sweet-taste-receptor machinery can 
be found in enterocytes (Mace, Affleck, et al., 2007). Sugars and artificial sweeteners 
bind to the sweet-taste-receptor heterodimer T1R2/3 directly on the enterocyte and 
connect to the sugar transporters via αGustducin and/or αTransducin and the second-
messenger molecules PKCβII and Phospholipase βII (Kellett et al., 2008). This enables the 
enterocyte to directly and immediately regulate hexose-transport capacities upon 
luminal nutrient load. 
High levels of the ‘taste machinery’ proteins were also located in small-
intestinal EECs like GLP1-secreting L-cells. It has been suggested that EECs also regulate 
nutrient-transport capacities in enterocytes in an indirect, paracrine fashion 
(Margolskee et al., 2007). Indeed, GLP2 has been shown to upregulate SGLT1 in 
enterocytes and to rapidly lead to apical GLUT2 insertion (Cheeseman, 1997; Au et al., 
2002). αGustducin knockout mice show diminished GLP1 levels and when chronically fed 
a high-carbohydrate diet cannot up-regulate SGLT1 expression in enterocytes (Jang et 
al., 2007). These observations indicate the importance of the indirect regulatory 
function of EECs for the long-term regulation of sugar transport in enterocytes 
(Margolskee et al., 2007). 
The indirect, chronic EEC-mediated mechanism and the direct, short-term 
enterocyte-mediated mechanism are not mutually exclusive and could exist in parallel to 
regulate transport capacity. Despite the inconsistencies, the evidence suggests an 
involvement of the sweet-taste receptor T1R2/3 in the regulation of sugar transporters. 
This makes it an attractive target for the treatment of several metabolic pathologies by 
enabling the stimulation, and also the downregulation, of sugar-transport capacities.  
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An increase in nutrient uptake could help people with Fru malabsorption. Both 
directly activating the sweet-taste receptor on enterocytes and indirectly activating 
them via EECs to release GLP1/2 to upregulate GLUT5 expression or lead to apical GLUT2 
insertion in enterocytes are plausible scenarios to increase Fru absorption. 
Blocking of Fru absorption could help in the onset of non-alcoholic fatty-liver 
disease (NAFLD). Decreasing/retarding sugar uptake could reduce the postprandial 
glycaemic load and reduce the risk of developing metabolic syndrome. NAFLD has been 
associated with excess Fru consumption, leading to higher hepatic lipogenesis rates, 
which in turn can lead to an increased lipid burden (Moore et al., 2014). Besides dietary 
interventions, regulating the rate of Fru absorption to slow the postprandial Fru burden 
on the liver, as well as stimulating gut peptide secretion, could be beneficial with high 
Fru loads.  
In diabetes, the postprandial blood glucose levels increase rapidly, with 
homeostatic measures failing to clear the glucose to normal levels fast enough or at all 
(Laakso, 1999). It has been suggested that these hyperglycaemic spikes are involved in 
the onset of cardiovascular complications (Laakso, 1999). Similarly, slowing intestinal 
sugar absorption could be a potential therapy angle to help control postprandial 
hyperglycaemia. 
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Study the role of the sweet-taste receptor T1R2/3 in the regulation of intestinal sugar 
transport by dietary carbohydrates and artificial sweeteners. 
Hypothesis 
The sweet-taste receptor T1R2/3 is expressed on enterocytes and directly regulates 
sugar-transport capacities in enterocytes upon stimulation by sugars and artificial 
sweeteners. 
Objectives 
 Establish the Caco-2/TC7 cell line and radioactive sugar-uptake assay to study 
the regulation of sugar uptake 
 Study the short-term regulation of sugar transport by dietary sugars in Caco-
2/TC7 cells 
 Evaluate the role of the sweet-taste machinery in the short-term regulation of 
sugar transport 
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2.4 Materials & Methods 
2.4.1 Cell culture  
Caco-2/TC7 cells were grown in high-D-Glucose (25 mM) Dulbecco’s modified 
Eagle’s medium (DMEM) (Sigma-Aldrich, Dorset/UK), containing 10% fetal bovine serum 
(FBS; Sigma-Aldrich), 50 units Penicillin and 50 µg Streptomycin (Pen/Strep; Sigma-
Aldrich), 0.1 mM MEM non-essential amino acids and additional 2 mM L-Glutamine 
(Sigma-Aldrich). The cells were grown in T25 flasks, split 1:20 once a week at ~80% 
confluence and seeded for experimentation at a density of 10,000 cells/cm2 in 24 
multiwell dishes (NUNC, Roskilde/DK). Medium was changed every other day until 
confluent and daily after reaching confluence. For experiments cell passages 38–50 were 
used. 
2.4.2 Radio-labelled sugar-uptake assay 
Assay conditions varied according to the experimental question and any 
modifications to the following standard protocol are indicated in figure 
legends/descriptions. Kreb’s buffer (KBS) necessary for the protocol contained 30 mM 
HEPES, 130 mM NaCl, 4 mM KH2PO4, 1 mM MgSO4 and 1 mM CaCl2, and the pH was 
adjusted to 7.4. For Na+-free KBS, NaCl was replaced with choline chloride.  
Cells were removed from the incubator, washed once with KBS and then 
preincubated in KBS optionally containing the inhibitors 500 µM PZ, 500 µM Phloretin 
(PT) or 10 µM Cytochalasin B (CB; Sigma-Aldrich), or D-Glu or Fru (Sigma-Aldrich), for 15 
min or 3 h respectively. Preincubation medium was then removed for uptake, but 3 h 
preincubation experiments had another wash with KBS included. Sugar uptake was 
measured by exposing cells to 10 mM D-Glu (Perkin-Elmer, Cambridge/UK) or Fru 
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(American radiolabelled chemicals, St Louis, MO, US) containing 0.1 µCi/ml 14C radio-
labelled sugar molecules. Absolute uptake was corrected for simple diffusion by 
measuring 14C L-Glucose (Perkin-Elmer) diffusion. Cells were lysed with 500 µl 0.2% SDS 
in dH20 for 60 min at 37°C. 200 µl of cell lysate were added to 5 ml of Ecoscint A 
scintillation fluid (National Diagnostics, Hessle/UK) and radioactivity counts were 
measured on a liquid-scintillation counter (LS 6500, Beckman-Coulter, High 
Wycombe/UK). The amount of substrate in the lysate was calculated using the specific 
activity of the uptake media. 
2.4.3 RNA isolation 
Cells on 24-well plates were washed with ice-cold PBS and then lysed with 400 
µl cold TRIzol® reagent (Life Technologies, USA). RNA was then extracted, using a 
modified protocol based on Chomczynski & Sacchi (1987). 80 µl Chloroform and 96 µl 
RNase-free water were added to the cell lysate, and after vortexing thoroughly for 15 s 
incubated for 10 min on the bench. Tubes were then centrifuged at 13,000 RPM at 4°C 
for 10 min. The aqueous phase was transferred to a new tube and RNA was precipitated 
with ice-cold isopropanol in -20°C freezer for 30 min and then centrifuged 13,000 RPM 
at 4°C for 30 min. The resulting pellet was washed twice in 75% ethanol and centrifuged 
for 5 min at 13,000 RPM at 4°C. The ethanol was taken off and let sit on the bench to 
evaporate and was then redissolved in 30 µl water. The RNA concentration and purity 
were measured on a Nanodrop 2000 (Thermo Scientific, UK).  
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2.4.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
1 µg of RNA was digested using a RQ1 RNase-free DNase kit (Promega, UK) to 
get rid of any genomic contamination by incubating at 37°C for 30 min in a PTC-200 
Peltier Thermal Cycler (MJ Research, Canada), as indicated by the manufacturer’s 
protocol. Reverse transcription was performed using a High-Capacity cDNA reverse 
transcription kit (AppliedBiosystems, US) according to the manufacturer’s manual. The 
resulting cDNA was then diluted 1:10 for further transcriptomic analysis. 
PCRs were run with the FastStart Universal Probe Master according to the 
manufacturer’s protocol on a PTC 200 Peltier Thermal Cycler (MT Research) with the 
following set up (see Table 1 & Table 2). All Primers were obtained from IDT (Leuven, 
Belgium) and reconstituted with ultrapure water. For PCR assays, primers (Table 3) were 
diluted to a stock concentration of 10 μM and used at a final concentration of 900 nM. 
Table 1 Reaction setup for PCR 
Reagent Volume (µL) 
FastStart Universal Probe Master (ROX) 10 
Forward primer (900 nM) 1.8 
Reverse primer (900 nM) 1.8 
RNA-free water 4.4 
cDNA (1:10 dilution) 2 
Total Reaction Volume 20 
 
Table 2 PCR protocol 
 Step 1 Step 2 Step 3 Step 4 
Temperature (°C) 95 95 60 4 
Time (min) 10 0:15 1 ∞ 
Cycles 1 40 1 
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Table 3 Primer sequences used for gene-expression analyses 
Gene Forward primer: 5’-3’  Reverse primer: 5’-3’  Amplicon 
slc2a1 ggttgtgccatactcatgacc cagataggacatccagggtagc 66 bp 
slc2a2 gcatgtgccacactcacac aaaaccagggtcccagtga 89 bp 
slc2a3 gccctgaaagtcccagattt ttcatctcctggatgtcttgg 115 bp 
slc2a5 tccatttggagggtttatcg aacagcaaggcccctttt 78 bp 
slc5a1 ctggcaggccgaagtatg ccacttccaatgttactagcaaag 68 bp 
Slc5a4 aagctgctgcccatgttc  cgcattcagaaggtaccacac 94 bp 
tas1r2 tgaagggcattgttcacctt tgtagcctatcaccttcacttcat 91 bp 
tas1R3 ttcagtgcaacgcctcag cacgtggaaggtcaggttg 89 bp 
gnat3 agcgagatgcaagaaccgta cattcttatggatgatcttcatttgt 96 bp 
nos2 gaccagtacgtttggcaatg tttcagcatgaagagcgattt 73 bp 
 
2.4.5 Agarose gel electrophoresis 
PCR products were analysed on a 2% agarose gel made up of UltraPure Agarose 
(Life Technologies, Paisley/UK), Tris-Borate-EDTA buffer (45 mM Tris-borate/1 mM 
EDTA) and 5 µg Ethidium Bromide (Alfa Aesar, Heyshamm/UK). 4 µl of Blue/Orange 6X 
Loading Dye (Promega, Southampton/UK) were added to each PCR sample and run on 
the gel together with 12 µl DNA Ladder 100bp (Promega) at 120 V for 60 min. Gels were 
then visualised on a SynGene Genius Bioimaging system using GeneSnap, version 
6.00.26 (Synaptics, Cambridge/UK). 
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2.4.6 Statistics 
Data analysis and statistics were carried out either in Excel included in 
Microsoft Office Pro 2007, Version 12.0.6661.5000 SP3 MSO or in Graphpad Prism, 
Version 6.01. Data are given as arithmetic mean + standard deviation (SD). Significances 
were tested using the inbuilt two-sided T-Test of Excel, and ANOVA was tested in Prism 
with a Tukey post-hoc test with Bonferroni correction. A P-value of 0.05 or less was 
considered statistically significant.  
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2.5 Results 
2.5.1 D-Glu & Fru uptake is carrier-mediated and linear in Caco-2/TC7 
cells 
Caco-2 cells are an established and widely used model for the study of 
transepithelial transport (Delie & Rubas, 1997). A substantial amount of time has gone 
into the optimisation of growth, differentiation and assay protocols, to use the Caco-2 
cells as a model of enterocytes (data not shown). We decided to use the Caco-2/TC7 
sub-clone with the protocols outlined in 2.4. This sub-clone has a higher expression of 
sugar transporters and hence higher sugar-uptake capacities than the parental strain 
(Chantret et al., 1994). All the following experiments in this chapter use cells grown and 
differentiated for 21 ±2 days in growth medium containing D-Glu at 25 mM. Sugar 
uptake assays are performed in 24-well dishes with cells attached to the bottom. 
To establish our cell system and test our radio-labelled uptake assay we 
incubated cells in 10 mM D-Glu or L-Glu uptake media for a time course ranging from 1-
30 min. Uptake of L-Glu, a measure for simple diffusion as it cannot be absorbed by any 
known transporter, is at a very low rate and stays below 20 nMoles at 30 min (Fig. 12).  
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Fig. 12 Carrier-mediated C14 10 mM D-Glu/Fru uptake over time in Caco-2/TC7 cells. 
Differentiated Caco-2/TC7 cells were incubated in 10 mM C14 D-Glu/Fru/L-Glu uptake media for 
1, 5, 10 or 30 min and cellular uptake was measured. Data are expressed as nMoles uptake/well ± 
SD of n=4 per condition. 
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D-Glu and Fru uptake is readily detected above the simple diffusion ‘baseline’ 
set by L-Glu, indicating carrier-mediated uptake. Furthermore, uptake levels appear 
linear between 1 and 10 min, but then lag towards 30 min. We therefore used 10 min 
for further uptake experiments. 
2.5.2 D-Glu transport is regulated by D-Glu in Caco-2/TC7 cells 
To establish if our in vitro model is able to regulate sugar uptake upon nutrient 
availability, we incubated differentiated Caco-2/TC7 cells in KBS with concentrations of 
D-Glu between 2.5 and 75 mM for 3 h to mimic the physiologic situation and measured 
D-Glu-uptake capacity. D-Glu uptake is significantly more up-regulated the higher the 
concentration of D-Glu is in the preincubation media (Fig. 13). Uptake increased by 73% 
and 309% between 2.5 and 25 mM and 2.5 and 75 mM, respectively. 















































Fig. 13 Carrier-mediated C14 D-Glu uptake in Caco-2/TC7 cells after 3 h D-Glu preincubation. 
Differentiated Caco-2/TC7 cells were incubated for 3 h in KBS including D-Glu at the indicated 
concentrations. Osmolarity was adjusted for by adding Mannitol. D-Glu uptake was measured 
with radio-labelled D-Glu. Uptake is corrected for simple diffusion of L-Glu. Data are expressed as 
nMoles uptake/well/10min ± SD of n=4 per condition. *P < 0.05, **P < 0.01, ***P < 0.001, ns = 
not significant. 
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2.5.3 Dissection of transporters responsible for higher D-Glu transport 
Previous studies have shown that SGLT1, GLUT2 and GLUT5 are the main 
hexose-transporters in enterocytes in humans and rodents (Ferraris, 2001). To identify 
which hexose transporter genes are present and could contribute to the observed 
upregulation seen in Fig. 13, we performed RT-PCR on differentiated Caco-2/TC7 cells. 
 Gene transcripts for slc5a1/SGLT1, slc2a2/GLUT2 and slc2a5/GLUT5, 
transporters for D-Glu, D-Glu+Fru or Fru, respectively, are expressed as expected in 
enterocytes (Fig. 14). In addition, the D-Glu transporters slc2a1/GLUT1 and 
slc2a3/GLUT3 are highly expressed in Caco-2/TC7 cells (Fig. 14). 
 
Fig. 14 Gene expression of hexose transporters in Caco-2/TC7 cells. Gene expression for SGLT1 
(slc5a1), GLUT2 (slc2a2), GLUT5 (slc2a5), GLUT1 (slc2a1) and GLUT3 (slc2A3) at 21 days of culture 
of Caco-2/TC7 cells. Shown are the marker ladder (M), one representative sample (cDNA), a 
reverse transcriptase negative (RT-) and non-template control (NTC) for each gene. 
To determine if the up-regulation in D-Glu transport seen in Fig. 13 is mediated 
by SGLT1 and/or GLUT2, we measured uptake of D-Glu in the presence of inhibitors. 
Phloridzin (PZ) is known to inhibit only SGLT1 (Helliwell & Kellett, 2002), whereas 
Phloretin (PT) only inhibits GLUT2 (Kwon et al., 2007). Cytochalasin B (CB) inhibits GLUT 
1-4, 7, 8. Inconsistent with previous publications (Zheng et al., 2011), we were not able 
to detect inhibition by any of the inhibitors (PZ, PT, CB) at  25 mM D-Glu preincubation 
concentration (Fig. 15). At 75 mM D-Glu neither PZ nor CB decreased uptake, but PT was 
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able to inhibit transport by ~33%. This would indicate an involvement of GLUT2 in the 
upregulation of D-Glu transport. As PZ does not inhibit transport at 25 mM and as PT, 
but not CB inhbits transport at 75 mM possible reasons for this observation are 
discussed later and further confirmation is required. 
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Fig. 15 Carrier-mediated D-Glu uptake in Caco-2/TC7 cells. Differentiated Caco-2/TC7 cells were 
incubated for 3 h in KBS including D-Glu at the indicated concentrations. Osmolarity was adjusted 
for by adding Mannitol. Uptake was measured in the presence of inhibitors of sugar transporters; 
Phloridzin (PZ) & Phloretin (PT) at 500 µM, Cytochalasin B at 10 µM. The control has DMSO added 
at a final concentration 0.1%. Uptake is corrected for simple diffusion of L-Glucose. Data are 
expressed as nMoles uptake/well/10min ± SD of n=4 per condition. *P < 0.05, **P < 0.01, ***P < 
0.001, ns = not significant. 
GLUT2 is a known D-Glu, but also Fru transporter. To determine if the 
upregulation of D-Glu was caused by GLUT2 we repeated the experiment, but measured 
Fru uptake after D-Glu preincubation. Although Fru uptake in Caco-2/TC7 cells is lower 
than D-Glu uptake, an acute and statistically significant upregulation can be detected 
(Fig. 16a). Comparing the 2.5 mM with 75 mM preincubation concentration, Fru uptake 
is ~81% higher.  
We added PT and CB to the uptake media to dissect the transport mechanism. 
As seen in Fig. 16b, at 25 mM preincubation concentration Fru uptake is inhibited by PT 
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by ~60%, but not by CB, which indicates GLUT2 activity. At the higher concentration of 
75 mM of D-Glu, PT inhibits Fru uptake by ~43% and CB by ~55%, indicating involvement 
of GLUT2, but not GLUT5. 
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Fig. 16 Carrier-mediated C14 Fru uptake in Caco-2/TC7 cells after 3 h D-Glu preincubation. 
Differentiated Caco-2/TC7 cells were incubated for 3 h in KBS including D-Glu at the indicated 
concentrations. Osmolarity was adjusted for by adding Mannitol. a: Fru uptake was measured 
with radio-labelled Fru. b: Uptake was measured in the presence of inhibitors of sugar 
transporters; Phloretin (PT) at 500 µM, Cytochalasin B at 10 µM. The control has DMSO added at 
a final concentration 0.1%. Uptake is corrected for simple diffusion of L-Glucose. Data are 
expressed as nMoles uptake/well/10min ± SD of n=4 per condition. *P < 0.05, **P < 0.01, ***P < 
0.001, ns = not significant. 
Taken together, this suggests that Caco-2/TC7 cells are able to respond to short-
term stimulation (3 h), enabling them to upregulate D-Glu- and Fru-uptake capacities. 
Yet a dissection of which transporters are responsible for the increased uptake was not 
fully achieved.  
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2.5.4 The sweet-taste receptor T1R2/3 does not regulate sugar 
transport in Caco-2/TC7 cells 
It has been described that the rodent intestine stimulates GLUT2 
expression/apical translocation via the sweet-taste receptor T1R2/3 (Mace, Affleck, et 
al., 2007). To determine if the sweet-taste receptor T1R2/3 is expressed on a 
transcription level in Caco-2/TC7 cells, we extracted RNA from differentiated cells for 
subsequent RT-PCR. As seen in Fig. 17, only tas1r3 (T1R3) is expressed, but not tas1r2 
(T1R2) or the downstream signalling molecule αGustducin (gnat3). 
 
Fig. 17 Gene expression of the sweet-taste machinery in Caco-2/TC7 cells. Gene expression of 
αGustducin (gnat3), T1R2 (tas1r2) and T1R3 (tas1r3) at 21 days of culture of Caco-2/TC7 cells. 
Shown are the Ladder (M), one representative sample (cDNA), a reverse transcriptase negative 
(RT-) and non-template control (NTC) for each gene. 
Knockout mouse models have shown that T1R2 or T1R3 on their own can still 
sense natural sugars at higher molarities, but double knockouts completely lose 
functional sweet sensing (Zhao et al., 2003). Furthermore, HEK-293 cells transfected 
with only T1R3 also showed responses to high molarities of sucrose (Zhao et al., 2003). 
To test if T1R3 can be functional on its own in Caco-2/TC7 cells, we added the T1R3 
inhibitor Lactisole to preincubation media and measured D-Glu uptake.  As 
demonstrated in Fig. 18a, Lactisole does not inhibit the acute upregulation of D-Glu. 
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Furthermore, we added sweet-taste-receptor agonists in the form of the artificial 
sweeteners AcesulfameK and Sucralose during the preincubation in the 
presence/absence of Lactisole. Neither is D-Glu uptake enhanced by the added artificial 
sweeteners, nor is transport activity inhibited by the added Lactisole (see Fig. 18b), 
indicating no functional sweet-taste receptor in Caco-2/TC7 cells.  
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Fig. 18 Regulation of D-Glu uptake by the sweet-taste receptor T1R2/3. Caco-2/TC7 were 
seeded at a density to reach confluence at day 7 and grown for a total of 21 days to differentiate. 
a: Cells were incubated for 3 h in KBS including D-Glu at the indicated concentrations in the 
presence of Lactisole at 500 µM. The control contains the same amount of solvent (ddH20). b: 
Cells were incubated with 75mM D-Glu in the presence of 10 mM AcesulfameK K (AceK) or 
Sucralose with the addition Lactisole at 500 µM. Osmolarity was adjusted for by adding Mannitol. 
D-Glu uptake was measured. Uptake is corrected for simple diffusion of L-Glucose. Data are 
expressed as nMoles uptake/well/10min ± SD of n=4 per condition. *P < 0.05, **P < 0.01, ***P < 
0.001, ns = not significant. 
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2.5.5 HFCS, but not sucrose or fructose, stimulates sugar transport in 
Caco-2/TC7 cells 
Dietary Fru is able to regulate Fru-transporter activity (Corpe & Burant, 1996). 
In alignment with the previous experiments, we sought to study if the sweet-taste 
receptor is involved in the regulation of Fru transport. As the main forms of Fru in our 
diet are sucrose and HFCS, and to a smaller degree free Fru, we preincubated cells with 
increasing concentrations of sucrose, a 1:1 mix of D-Glu+Fru or Fru for 3 h and 
subsequently measured D-Glu and Fru uptake. It has been suggested that HFCS 
stimulates sugar absorption to a higher degree than sucrose as it skips the rate-limiting 
cleavage of sucrose by brush-border-bound sucrose-isomaltase. 
Cells did not react to the higher concentration of sucrose with increased D-Glu 
or Fru uptake (Fig. 19a+b). After preincubating cells for 3 h in HFCS D-Glu uptake, but 
not Fru uptake, increased significantly (Fig. 19c+d). The upregulation is likely due to the 
free D-Glu molecules, comparing it with sucrose. Adding Lactisole, we saw that the 
upregulation in D-Glu uptake after HFCS preincubation was not mediated by the sweet-
taste receptor (Fig. 19c), confirming our data from section 2.5.4. 
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Fig. 19 Stimulation of D-Glu/Fru transport with sucrose and HFCS in Caco-2/TC7. Differentiated 
cells were incubated for 3 h in KBS including sucrose (a, b) or HFCS (c, d) at the indicated 
concentrations. Osmolarity was adjusted for by adding Mannitol. D-Glu uptake (a, c) or Fru 
uptake (b, d) was measured. Lactisole at 500 µM was added to block the sweet-taste receptor. 
Uptake is corrected for simple diffusion of L-Glucose. Data are expressed as nMoles 
uptake/well/10min ± SD of n=4 per condition. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not 
significant. 
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Fig. 20 Stimulation of D-Glu/Fru transport by Fru in Caco-2/TC7 cells. Differentiated cells were 
incubated for 3 h in KBS including Fru at the indicated concentrations. Osmolarity was adjusted 
for by adding Mannitol. D-Glu uptake (a) or Fru uptake (b) was measured. Uptake is corrected for 
simple diffusion of L-Glucose. Data are expressed as nMoles uptake/well/10min ± SD of n=4 per 
condition. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant. 
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2.6 Discussion 
The gastrointestinal tract is the first barrier in contact with nutrients and is a 
complex endocrine organ integrated into whole body metabolism. It has evolved 
intricate mechanisms to acutely and chronically regulate its transport capacities upon 
postprandial nutrient load. Since the late 1990s a new concept has been that the gut 
senses foods to induce an appropriate response (Raybould, 1998). The molecular 
mechanisms by which sugar transport is regulated are not well studied, and 
controversial. Two models exist, both using the sweet-taste receptor to regulate hexose-
transport capacities: a direct model where the sweet-taste receptor directly regulates 
sugar transport capacities on enterocytes and an indirect model where EECs sense 
nutrients and regulate transport function in neighbouring enterocytes.  
We used the intestinal Caco-2/TC7 cell model to identify the role of the sweet-
taste receptor T1R2/3 in the regulation of intestinal sugar transport by dietary 
carbohydrates. We found an acute response of D-Glu transporters after stimulating cells 
with increasing concentrations of D-Glu, which was potentially mediated via GLUT2 but 
was independent of the sweet-taste receptor. 
We readily detected sugar uptake using our cell model and uptake assay and 
also detected upregulated D-Glu and Fru transport upon 3 h short-term stimulation with 
D-Glu. This indicates that monosaccharide load can be sensed and transport regulated. 
Applying gene-expression techniques, we detected expression of the small-intestinal 
sugar transporters SGLT1, GLUT2 and GLUT5, as expected. Using inhibitors to dissect 
transport pathways at the basal level of 25 mM D-Glu preincubation concentration we 
were not able to establish which transporters are responsible for the observed 
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upregulation. In contrast, at 75 mM D-Glu we detected PT sensitivity, indicating GLUT2 
activity. This observation is in alignment with the direct model of regulation. 
To study the existence and functionality of the sweet-taste receptor in Caco-
2/TC7 cells, we analysed expression of tas1r2, tas1r3 and gnat3 at the mRNA level. We 
were only able to detect transcripts of tas1r3, indicating a functional sweet-taste 
receptor cannot be existent in Caco-2/TC7 cells. Adding artificial sweeteners or Lactisole 
in preincubation media to stimulate/block the sweet-taste receptor, we saw no 
significant enhancement or inhibition of transport, indicating that D-Glu sensing in Caco-
2/TC7 cells may not be mediated via the sweet-taste receptor. 
Since Caco-2/TC7 cells only express tas1r3, and it has been shown that tas1r2 
knockout mice can still sense sugars, although not artificial sweeteners (Zhao et al., 
2003), we expanded our work to study and compare the sensing of sucrose, HFCS and 
Fru in Caco-2/TC7 cells. Incubating cells with increasing concentrations of sucrose or Fru 
showed no up-regulation in transport of D-Glu or Fru. In contrast, HFCS preincubation 
showed upregulated D-Glu uptake, which is likely due to the free D-Glu available in HFCS 
to stimulate transport activity, which is in support of our previous data. 
The lack of a functional sweet-taste receptor and the sensing specificity for D-
Glu but not for Fru, suggest another sensing mechanism. In fact, it has been suggested 
that a novel sugar sensor, is involved in intestinal nutrient sensing with high specificity 
for D-Glu (Diez-Sampedro et al., 2003). First described as expressed in intestinal 
cholinergic neurons and smooth muscle, it has also been shown to be expressed in the 
intestinal mucosa of rats (Freeman et al., 2006). We speculate that SGLT3 is potentially 
involved in D-Glu sensing on the enterocyte, and more research is needed. 
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Since Caco-2/TC7 cells only express T1R3 on a transcription level and we did not 
see functionality regarding D-Glu sensing, we expanded our work to Fru and sucrose. We 
were not able to detect transport activation with increasing concentrations of sucrose or 
free Fru. Either sucrose is not sensed or Sucrase-Isomaltase is rate-limiting the 
availability of mono-saccharides, and hence transporter expression or transporter 
translocation to the apical membrane does not need to be upregulated. Le Gall et al. 
reported in 2007 that Caco-2/TC7 cells can react to Fru incubation with increased SGLT1, 
GLUT2 and GLUT5 mRNA expression and that insulin is able  reduce GLUT2 trafficking to 
the brush boarder (Tobin et al., 2008). The observed SGLT1 and GLUT5 mRNA 
upregulation was blockable with Lactisole. The increased mRNA levels may not carry 
over into increased uptake levels, although this is in strong contrast to animal studies, as 
it has been shown that Fru regulates GLUT5 transport capacity (Corpe et al., 1996). 
Our findings are in contrast to previous literature and models (Le Gall et al., 
2007; Zheng et al., 2011; Zheng & Sarr, 2013). The Brot-Laroche lab shows functional 
sugar sensing in Caco-2/TC7 cells and upregulated sugar-transporter transcripts for 
SGLT1 and GLUT5 upon stimulation, which is blockable by Lactisole. They also show 
T1R2 and T1R3 protein expression using immunohistochemistry, but only show RT-PCR 
data for gnat3 and tas1r3, but not tas1r2 (Le Gall et al., 2007). We question why a PCR 
for tas1r2 has not been carried out/included in the publication. Further confirmation of 
the immunohistochemistry data is needed, as the specificity of the antibodies used is 
not shown. Furthermore, Le Gall’s study starved differentiated Caco-2/TC7 cells for 2 
days prior to performing experiments. Not only is this unphysiological, but from our 
experience it is very detrimental to cell health/survival; 48 h starvation resulted in 
mono-layer detachment and cell death for us. 
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Michael Sarr’s group used very similar protocols to us, but utilised the parental 
Caco-2 cell strain and they were able to show dissection of transport pathways with PZ 
and PT (Zheng et al., 2011). We therefore acquired the parental Caco-2 strain and 
repeated our Caco-2/TC7 experiments, but achieved very similar results to the Caco-
2/TC7 results (data not shown). Zheng et al. also studied the stimulation of D-Glu 
transport by artificial sweeteners and confirmed our results (insensitivity to T1R3 
agonists). Yet they were able to demonstrate that with only a 5 min uptake stimulation 
of carrier-mediated D-Glu uptake with AcesulfameK was blockable with CB or a PLCβII 
inhibitor (Zheng & Sarr, 2013). The activation of the sweet-taste receptor was able to 
increase D-Glu uptake at concentrations higher than 25 mM although no statistical 
analysis was performed to support their data.  
2.7 Limitations of the study 
Despite the interesting findings from our study, several limitations appear. The 
variable findings in our inhibitor experiments to dissect transport pathways and the lack 
of sweet-taste-receptor mediation could be due to our cell line. As Caco-2 cells are a 
colonic adenocarcinoma cell line that spontaneously differentiates to an enterocyte-like 
phenotype, certain cancer-like characteristics cannot be removed during their 
spontaneous differentiation and we show high expression of GLUT1 and GLUT3. 
 Furthermore, it is very common for cell lines to evolve and change phenotypic 
properties upon long-term passaging or wrong culture conditions, which has been 
extensively written about regarding Caco-2 cells (Sambuy et al., 2005). Our Caco-2/TC7 
clone was obtained many years ago directly from the Brot-Laroche lab and has since 
been handled by many different researchers and students in the lab. It stands to reason 
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that there has been a change in the cell’s functional characteristics. We also obtained a 
parental Caco-2 cell line from another lab and a complete fresh stock from ATCC/Sigma 
in order to compare sub-clones with each other and to the literature, and saw very 
similar results to the ones demonstrated. It would be of interest to repeat our 
experiments in other enterocyte in vitro models such as RIE-1 or IEC-6 cells. 
It cannot be excluded that assay conditions were not optimal regarding the 
experimental questions, especially regarding inhibitor studies to dissect transport 
pathways. Yet we used the same assay conditions for SGLT1 or GLUT2 expressing 
oocytes to study inhibition by PZ, PT and CB which indicates that our sugar uptake 
conditions are correct (data not shown). The high expression of GLUT1 and GLUT3 may 
overshadow the uptake by SGLT1, GLUT2 and GLUT5 and hence render the cells 
insensitive to the inhibitors. 
Taken together, it leads us to question the suitability of Caco-2 cell lines as an in 
vitro model to study intestinal sugar sensing in the regulation of sugar transport. 
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2.8 Conclusion 
In conclusion, our in vitro data are in line with human studies showing that only 
natural sugars, but not artificial sweeteners can lead to small-intestinal functional 
responses, such as slowed gastric emptying, enhanced sugar transport, the release of 
incretins (Fujita et al., 2009; Ma et al., 2009; Ma et al., 2010). Our data suggest that the 
observed acute upregulation of D-Glu uptake after D-Glu or HFCS preincubation is not 
mediated via the sweet-taste receptor, but potentially via another sensor such as SGLT3 
or directly by the sugar transporters.  
Based on our findings we support the direct model in line with Kellett, Brot-
Laroche and Sarr via another sensing mechanism, but only for D-Glu and HFCS. For Fru 
and sucrose we suggest an indirect model of transport regulation mediated via EECs. 
Further research (e.g. in EEC cell models) and other, more physiological enterocyte 
models are needed to elucidate exact mechanisms. 
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3 DIURNAL REGULATION OF NUTRIENT SENSORS ALONG THE 
ALIMENTARY TRACT 
3.1 Summary 
Background Distributed along the length of the gastrointestinal tract are macronutrient 
sensing mechanisms that regulate intestinal nutrient transport capacity and the release 
of peptides that influence gastrointestinal function and energy balance. Recent data has 
shown a circadian rhythm of GLP1 secretion. However, there have been no reports 
showing clock gene regulated expression of macronutrient sensors. 
Aims We hypothesised that macronutrient sensors and gut peptides display a diurnal 
rhythm anticipatory to nocturnal feeding in the alimentary tract that is controlled by 
clock genes.  
Methods To test our hypothesis we studied the expression levels of clock genes, 
nutrient sensors and gut peptides in the alimentary tract of nocturnal feeding rodents. 
We applied gene expression profiling techniques to further study clock-controlled genes 
in the murine tongue.  
Results The novel sugar sensor SGLT3a showed clear rhythmicity in the small intestine 
and SGLT3b demonstrated a clear rhythm in the stomach, whereas T1R1, T1R2 and T1R3 
displayed a much more limited rhythm. The tongue showed robust clock gene activity, 
but no rhythmicity in the studied nutrient sensors. Microarray analysis on the tongue 
revealed a high regulation of bitter sensors, enzymes and gut peptides, and also of 
genes involved in immunity and signal transduction. 
Conclusions Taken together, this data suggests a novel interaction between clock genes 
and nutrient sensor mechanisms in the alimentary tract that is possibly involved in the 
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food-entrainable part of the mammalian clock. Disturbances in clock gene/nutrient 
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3.2 Background 
3.2.1 Circadian clock 
Most living organisms on earth depend upon the energy harnessed from 
sunlight. The daily pattern of night and day caused by the earth’s rotation around its 
own axis has influenced the evolution of life forms and species. Circadian adaptions can 
be found in all branches of the tree of life, as they provide advantages for organisms to 
anticipate environmental oscillations. This is most obvious in plants and the daily change 
of leaf movements of the Tamarind tree was described as early as 400 BC (Bretzl, 1903). 
In animals, the circadian system regulates daily rhythms of behaviour and 
physiology, enabling organisms to anticipate periodic alterations in the environment and 
adjust necessary adaptive mechanisms. The most obvious of these adaptions is 
sleep/wake cycles. Animals can be categorised according to their highest activity levels, 
which usually means food-search behaviour; these groups are described as during the 
day (diurnal), during the night (nocturnal), in the twilight (crepuscular), in the morning 
twilight (matutinal) or in the evening (vespertine). Different processes in the body need 
to be active during certain times of the day, and others shut off so as not to waste 
energy/resources. Such behaviour enables optimal reproduction and energy utilisation 
(Panda, Hogenesch, et al., 2002). 
The behavioural and physiological adaptations are governed by a highly 
developed, conserved and complex circadian machinery in animals. Light signals on the 
retina are sent to the suprachiasmatic nucleus (SCN) in the brain via the 
retinohypothalamic tract. The SCN is termed the ‘master clock’, as it synchronises the 24 
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h light-dark cycle and entrains the body with necessary phenotypic adaptions. Peripheral 
clocks are also found in all tissues and are governed by the SCN. The central and 
peripheral clocks are established on a molecular level. The canonical mechanism is a 
transcriptional–translational feedback loop that drives a ∼24 h expression pattern of the 
core clock machinery. CLOCK and BMAL1 proteins, members of the basic helix-loop-helix 
(bHLH) family, dimerise and bind E-Box elements of target genes to enhance 
transcription. Two target gene groups are period (per1-3) and cryptochrome (cry1, cry2), 
which heterodimerise, translocate into the nucleus and promote histone deacetylase 
binding, which represses CLOCK:BMAL1 expression. This completes the negative 
feedback loop and establishes an oscillating pattern (see Fig. 21a).  
 
Fig. 21 Mechanism of the molecular clock. A: The canonical, core mechanisms governed by 
CLOCK, BMAL1, CRY and PER inducing a transcriptional–translational negative feedback loop.  B: 
The emerging model of the cellular clock mechanism with a variety of transcription and nuclear 
factors regulating and fine tuning the cellular circadian rhythm. (Figure reproduced from ZHAO et 
al., 2014). 
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Over the years, knockout, mutation and experimental studies have revealed a 
more complex and fine-tuned model (Fig. 21b). A host of nuclear factors such as the 
retinoic acid-related orphan nuclear-receptor family, including REV-ERB and RXR, bind 
response elements (RE) in promotors of core clock genes to stimulate/repress 
transcription. Nuclear receptors have a variety of dimerisation partners such as 
Peroxisome Proliferator-activated receptors (PPAR), which in turn can be bound by a 
multitude of ligands and metabolites (e.g. fatty acids, Vitamin D, retinoic acid; Fig. 21b). 
Not only do clock genes and nuclear factors regulate each other, but it has been 
suggested that ~10% of cellular gene transcripts are diurnally regulated (Panda et al., 
2002). These genes are termed clock-controlled genes (CCGs). 
3.2.2 Circadian clock and metabolic disease 
In today’s society meal timing and patterns have changed, and this is most 
evident in shift workers. It has been suggested that these changes increase the risk for 
metabolic diseases (Pan et al., 2011). Evidence is accumulating on how perturbations of 
clock systems and sleep constitute risk factors for diseases (e.g. cancer) and metabolic 
disorders such as obesity, diabetes mellitus and cardiovascular disease (Zelinski et al., 
2014). Polymorphisms in circadian regulatory genes have been linked to obesity and 
type 2 diabetes (Scott et al., 2008).  Disruption of arntl1/BMAL1 gene function caused an 
abnormal metabolic profile with hyperleptinemia, glucose intolerance and dyslipidaemia 
(Rudic et al., 2004). Clock/CLOCK mutant mice not only have disrupted sleep and feeding 
patterns, but are hyperphagic and develop obesity (Turek et al., 2005). Similarly, 
disruption of sleep and sleep patterns such as in shift workers have been shown to 
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disturb circadian rhythm and increase the risk of metabolic syndrome (Lund et al., 2001; 
Pan et al., 2011). Sleep–wake cycles can become disturbed and light exposure and 
eating during the night pose time-inappropriate cues that disrupt clock mechanisms in 
the SCN, in the periphery and on a cellular level. Altered circadian rhythmicity could be 
affecting the body through both disrupted metabolism and consequent behavioural 
modification, producing a vicious cycle of altered cellular machinery, activity levels and 
adverse dietary choices, leading to a disease state. 
Maintaining circadian rhythms protects the body from metabolic diseases 
(Nohara et al., 2015). Behavioural, environmental and dietary measures are at the core 
of maintaining and stabilising these rhythms, but targeting clock genes and CCGs with 
pharmacological agents is also an emerging possibility (Challet, 2013). Small molecules, 
dubbed ‘clock-amplitude-enhancing small molecules’, have been identified and are able 
to target core clock genes. These molecules have been shown to have stabilising and 
beneficial properties on sleep and metabolism (Chen et al., 2012; Chen et al., 2013). 
The central clock is synchronised and reset every day by light on the retina, 
termed ‘Light-entrainable oscillator’ (LEO), but food and feeding regimens have been 
also shown to synchronise a ‘food-entrainable oscillator’ (FEO). The FEO increases ‘food-
anticipatory activity’ before mealtime, which raises general activity levels and food-
finding patterns. The FEO also prepares the body for feeding, including body 
temperature and corticosterone and growth-hormone levels, as well as intestinal 
motility (Krieger, 1974; Moberg et al., 1975; Comperatore & Stephan, 1987).  
The FEO is thought to be synchronised by an array of neuronal and humoral 
signals from the gastrointestinal tract, including gut peptides and also blood-glucose and 
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insulin levels (reviewed in Carneiro & Araujo, 2009). Yet the exact molecular identity of 
the sensors and the precise mechanisms responsible for FEO entrainment are not clear. 
It has been shown that a host of intestinal processes display diurnal rhythmicity. 
Nutrient transporters such as hexose and peptide transporters on enterocytes display 
circadian rhythmicity anticipatory to feeding (Corpe & Burant, 1996; Pan et al., 2002). 
GLP1 has been demonstrated to have a circadian pattern of expression only very 
recently (Gil-Lozano et al., 2014). Insulin is secreted from the pancreas in a circadian 
fashion (Jarrett et al., 1972; Boden et al., 1996). A GLP1-receptor agonist, Liraglutide, has 
been shown to restore the rhythmicity of clock genes and insulin secretion in pancreatic 
β-cells of diabetic mice (Wang et al., 2015). The regulation of GLP1 secretion is taste-
receptor-dependent (Gerspach et al., 2011; Steinert et al., 2011). Furthermore, sweet-
taste recognition in humans displays diurnal rhythmicity (Nakamura et al., 2008). Yet 
there are no reports in the literature demonstrating a diurnal pattern of expression for 
the umami- and sweet-taste receptors or the novel D-Glu sensor SGLT3 in the 
alimentary tract. Their role as sensors implicate their ability to mediate food 
entrainment cues into the peripheral and central clock. Since insulin and GLP1 secretion 
display circadian rhythms, we hypothesised that nutrient sensors in the alimentary tract 
also display diurnal rhythmicity anticipatory to feeding.  
Better understanding of circadian rhythmicity of chemosensors in the 
gastrointestinal tract could help to optimise meal timing and also to avoid metabolic 
problems observed in shift workers. 
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3.3 Chapter Overview – Diurnal expression of nutrient sensors 
along the alimentary tract 
 
Aims 
Evaluate the diurnal expression of nutrient sensors in the murine alimentary tract. 
Hypothesis 
Mice show diurnal rhythms of nutrient sensors in the alimentary tract anticipatory to 
nocturnal feeding, which are regulated by the mammalian clock machinery. 
Objectives 
 Evaluate diurnal rhythms of nutrient sensor gene expression in the alimentary 
tract of mice 
 Study the promotors of nutrient sensors for circadian E-Box elements 
 Assess the expression profiles in the tongue for diurnally regulated genes 
  
Chapter 3: Diurnal regulation of nutrient sensors along the alimentary tract 
 
- 82 - 
3.4 Materials & Methods 
3.4.1 Animal ex vivo studies  
Sixteen juvenile male CD-1 mice were kept for six weeks under standard 
conditions with free access to standard chow and water. A standard 12-hour dark/light 
cycle, with the start of the light cycle at 6am and the start of the dark cycle at 6pm, was 
under automatic regulation. The mice were randomly divided into two groups (7am and 
7pm) before being euthanised by cervical dislocation whilst under halothane 
anaesthesia. 7am mice (n=8) were euthanised between 6 and 7am, whilst 7pm mice 
(n=8) were euthanised between 6 and 7pm. Tissues were dissected into tubes and 
immediately snap-frozen in liquid nitrogen for further RNA extraction.  
Due to the small tissue size available from the CD-1 mouse samples, more tissue 
was dissected from C57BL/6 mice. Fifteen eleven-week-old male mice were housed with 
a 12 h light/dark cycle. They were randomly assigned into two groups (7am: n = 8, 7pm: 
n=7). As before, mice were anaesthetised and euthanised and tissues were dissected 
into tubes and immediately snap-frozen in liquid nitrogen for further protein extraction. 
Transcriptomic findings found in the CD-1 tissues were confirmed in C57BL/6 
tissues to justify the proteomic analysis. 
3.4.2 RNA extraction 
1 ml RNAlater®-ICE solution (Life Technologies, USA) was added to tissues and 
tubes were transferred to a -20°C freezer to penetrate the tissues overnight. 15 mg of 
tissue were then weighed out into a 2 ml tube with a 5 mm steel bead (Qiagen, 
Netherlands) while kept on dry ice. 1 ml of Qiazol (Qiagen) was then added to 
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homogenise the tissues in a Qiagen TissueLyser for 3x30 s at 30 Hz. RNA was then 
extracted using an RNeasy Lipid Tissue Mini Procedure (Qiagen, Netherlands), following 
the manufacturer’s protocol. 
3.4.3 Microarray analysis 
400 ng of RNA was pooled together from each group (7am/7pm) and integrity 
was confirmed by analysing it on an Agilent Bioanalyzer chip. RNA was then labelled 
with a GeneChip® 3’ IVT Express Kit (Affymetrix, USA) and analysed using a GeneChip 
MouseGenome 430A 2.0 Array following the manufacturer’s instructions. Data was 
analysed using the GeneGo software (MetaCore™, version 6.19 build 65960 - Thomson 
Reuters).  
3.4.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
1 µg of RNA was digested as indicated in 2.4.4. The RNA was then reverse 
transcribed with a High capacity RNA-to-cDNA kit (Applied Biosystems, USA) according 
to the manufacturer’s protocol in a PTC-200 Peltier Thermal cycler. The resulting cDNA 
was diluted 1:10 in water for further analysis. 
Primers were designed by using Roche’s online ProbeFinder Software, ver. 2.50. 
The human genome was selected to design PCR assays over exon-exon borders for 
transcriptome specificity (Table 4). All primers were obtained from IDT (Leuven, 
Belgium) and reconstituted with ultrapure water to a stock concentration of 10 μM. 
cDNA was amplified using a FastStart Universal Probe Master (Rox) (Roche, 
Switzerland) mastermix with primers (see Table 4) at a concentration of 900 nM each, 
unless otherwise indicated. 2 µl of diluted cDNA were added, to achieve a total volume 
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of 20 µl. This amounts to ~10 ng cDNA per reaction. PCR was performed with the 
following protocol on a PTC-200 thermocycler: 10 min at 95°C for polymerase activation, 
40 cycles of 95°C annealing for 15 s and 1 min at 60°C for amplification. PCR products 
were visualised as outlined in 2.4.5. 
Table 4 Primer sequences and probes used in RT-PCR & real-time PCR 
Gene Forward primer: 5’-3’  Reverse primer: 5’-3’  Amplicon bp Probe # 
18s gcaattattccccatgaacg gggacttaatcaacgcaagc 68 48  
hprt1 tcctcctcagaccgctttt cctggttcatcatcgctaatc 90 95  
hmbs tccctgaaggatgtgcctac aagggttttcccgtttgc 73 79  
slc5a1 ctggcaggccgaagtatg ttccaatgttactggcaaagag 65 49  
slc2a2 gggccatcaacatgatcttc aatcatcccggttaggaaca 86 70  
slc2a5 agagcaacgatggaggaaaa ccagagcaaggaccaatgtc 64 94  
slc5a4a aaacccattcccgatgttc tcgattctttcctccttactgttc 71 107  
slc5a4b ccgattcctgatgttcacct atccgctcctctgtgttgtt 65 67  
gcg cacgcccttcaagacacag gtcctcatgcgcttctgtc 69 33  
cck tgatttccccatccaaagc gcttctgcagggactaccg 103 9  
gip caggtaggaggagaagacctcat cctagattgtgtcccctagcc 77 79  
ghrl ccagaggacagaggacaagc catcgaagggagcattgaac 70 17  
arntl1 tacagtggccctttgcatct cccaaattcccacatctga 72 47  
cry2 ccgcctgtgggacttgta ctccattcggtcaaacctg 130 49  
gnat3 tccaaagaactggagaagaagc tttcccagattcacctgctc 93 88  
gnat1 agagctggagaagaagctgaaa tagtgctcttcccggattca 95 89  
tas1r1 gggcctgataacactgacca tgctcgcctcatagctgac 85 74  
 
3.4.5 Real-time PCR 
Quantitative PCR was performed using the same master mix as in 3.4.4, but the 
total volume was changed to 25 µl including 2.5 µl cDNA. Furthermore, a Universal 
probe library (UPL) fluorescent probe was added (see Table 4) and real-time PCR was 
performed on an AB 7000 qPCR cycler (Applied Biosystems, USA).  
For relative quantification the ddCT method was performed using the reference 
genes 18s, hprt1 and hmbs for normalisation. 
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3.4.6 QuantiFast® tas1r2 & tas1r3 real-time PCR 
As we were not successful in quantifying expression of tas1r2 and tas1r3 with 
normal UPL assays, we used QuantiFast® Probe Assay kits (Qiagen) with predesigned 
primers and probes - tas1r2 (Cat. No: QF00096929) and tas1r3 (Cat. No: QF00030016) -
and followed the manufacturer’s manual. PCRs were performed on an AB 7000 qPCR 
cycler (Applied Biosystems, USA).  
3.4.7 Protein extraction 
15 mg of tissue was dissected on dry ice and added to a 2 ml tube with a 5 mm 
steel bead (Qiagen, Netherlands). 400 µl ice-cold protein-extraction buffer (1mM fresh 
DTT, 50mM Tris-HCl pH 7.4, 250mM Mannitol, 100mM NaCl, 1mM EDTA, 1mM EGTA, 
10% glycerol) containing 1x protease-inhibitor cocktail (Sigma-Aldrich P8340, Dorset/UK) 
was added to the tubes and immediately disrupted in a Qiagen TissueLyser for 2x60s at 
30 Hz and then kept on ice. Then 44 µl extraction buffer containing 10% Triton-X 100 
was added for a final concentration of 1% of Triton-X 100. Samples were then incubated 
on a rotating spinner for 30min at 4°C and then centrifuged at 13,000 RPM for 10 min at 
4°C. The protein-containing supernatant was transferred into a new tube. 
3.4.8 Bicinchoninic acid (BCA) assay 
Protein content was quantified using a PierceTM BCA Protein assay kit. Bovine 
serum albumin (Sigma Aldrich A9647, Dorset/UK) was made up at a concentration of 2 
mg/ml stock and diluted to 1, 0.5, 0.125 mg/ml to serve as standards. Protein samples 
were diluted 1:10 in water. 25 µl of standards and diluted samples were added to a 96-
well plate. Reagent A was mixed 50:1 with reagent B and then 200 µl was added to each 
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well. The plate was mixed for 30s on a plate mixer and then incubated for 30 min at 
37°C. Absorbance was measured at 562 nm on a BIO-TEK Synergy HT-1 
spectrophotometer. Concentrations of unknowns were calculated from a standard curve 
drawn in Microsoft Excel. 
3.4.9 Western blotting 
Protein lysates were made up at a final concentration of 5 µg/µl, including 4x 
NuPAGE® LDS sample buffer (Life Technologies) and 10x sample-reducing agent (Life 
Technologies). Samples were then heated for 5 min at 95°C and 20 µg were loaded onto 
a 4-12% gradient NuPAGE Bis-Tris Protein gels. Proteins and a Amersham ECL High-
Range Rainbow Molecular Weight Marker (GE Healthcare, Little Chalfont/UK) were 
separated for 55 min at 200 V in an XCell sure-lock tank with 1x NuPAGE® MOPS SDS 
running buffer (Life Technologies). The Western transfer was then performed using a 
Bio-Rad TurboBlot by sandwiching the gel between two filter papers soaked in cold 
Transfer buffer (25mM Tris-base, 75 mM Glycine, 10% Methanol, 0.1% SDS) and a 0.45 
µm Immobilon-P PVDF membrane (Merck Millipore, Cork/IRL). Proteins were 
transferred for 90 min at 20V with a 100 mA cut-off to avoid overheating and drying out 
of membrane.  
PVDF membranes were then blocked in 5% milk powder in TBS+Tween 0.1% 
(TBST) for 1 h. Blots were then rinsed 3x and washed for 3x 5 min in TBST. Primary 
antibodies were prepared at a concentration of 1:2000 in TBST with 0.05% Sodium Azide 
and blots were incubated over-night at 4°C. Antibodies were from Santa Cruz 
Biotechnology, Heidelberg/DE: βActin sc-130656, GLUT2 sc-31826, SGLT3 sc-134521. 
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The next day antibodies were removed and blots were rinsed 3x and washed for 3x 5 
min in TBST and blocked for 10 min. Anti-rabbit secondary antibody (sc-2004) was made 
up in blocking buffer at a final concentration of 1:2000, to be incubated for 1 h at room 
temperature while rocking. Blots were rinsed 3x and washed for 3x 10 min in TBST to 
then be visualised. Blots were rid of any excess wash buffer and placed on an acetate 
sheet and 800 µl ECL Prime (GE Healthcare, Little Chalfont/UK) was added according to 
the manufacturer’s protocol and they were then incubated for 3 min while rocking by 
hand. Luminescence generated by antibodies was visualised for 1-20 min using a 
SynGene G:BOX with the GeneSnap software, version 7.12 (Synaptics, Cambridge/UK). 
3.4.10 In silico promotor analysis 
To fetch the upstream sequence for a specific gene, we used the genome 
browser at UCSC (Kent et al., 2002). The mouse or human genome and the latest 
assembly (mouse: Dec. 2011 (GRCm38/mm10), human: Feb. 2009 (GRCh37/hg19)) were 
selected. The gene-accession number was pasted in the identifier field and ‘sequence’ 
chosen for output format before clicking on ‘get output’. On the next page ‘genomic’ 
was chosen and on the final page 5000bp was entered in the ‘Promotor/Upstream’ field 
to retrieve the sequence in text format. Promotor regions are automatically selected 
according to the orientation on the genome (sense or antisense). E-Box elements were 
then retrieved manually in Microsoft Word. 
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3.4.11 Statistics 
Data analysis and statistics were performed using Excel included in Microsoft 
Office Pro 2007, Version 12.0.6661.5000 SP3 MSO. Data are given as arithmetic mean + 
standard deviation (SD). Significances were tested using the inbuilt two-sided T-Test of 
Excel. A P-value of 0.05 or less was considered statistically significant. 
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3.5 Results 
3.5.1 Diurnal rhythm of sugar transporters in the gastrointestinal tract 
Diurnal rhythms of nutrient transporters have been described previously in rats 
(Corpe & Burant, 1996) and mice (Fatima et al., 2009). To confirm these findings and to 
have a baseline for our further experiments we analysed the diurnal rhythmicity of 
hexose transporters SGLT1, GLUT2 and GLUT5 in the small intestine of mice comparing 
the mRNA expression at 7am and 7pm. As seen in Fig. 22, a clear diurnal pattern with 
significant and high expression anticipatory to nocturnal feeding can be observed for all 
three transporters in all small-intestinal regions. Upregulations range from at least ~2- to 
4-fold at 7pm, which is consistent with the literature. 
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Fig. 22 Diurnal mRNA expression of hexose transporters in the murine small intestine. Whole 
duodenum, jejunum and ileum was dissected from six-week-old CD-1 mice at 7am or 7pm (n=8 
per group) for subsequent quantitative PCR of slc5a1 (SGLT1), slc2a2 (GLUT2) and slc2a5 
(GLUT5). Values were normalised against 3 reference genes and relative quantitation was 
performed using the ddCT method and are expressed relative to 7am. *P < 0.05, **P < 0.01, ***P 
< 0.001, ns = not significant. 
In order to confirm the mRNA findings on a proteomic level, we extracted total 
protein and performed Western blot analyses to relatively quantify the expression of 
GLUT2 normalised against βActin. GLUT2 protein levels follow the same pattern as we 
saw for the mRNA (Fig. 23). It appears that the rhythm is less pronounced with the 
jejunum and ileum, showing only a ~50% increase at 7pm (Fig. 23b+c). 
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Fig. 23 Diurnal protein expression of GLUT2 in the murine small intestine. Whole duodenum, 
jejunum and ileum was dissected from 10 week old C57BL/6 mice (n=8 per group) for subsequent 
protein extraction and Western blots of βActin and GLUT2. Representative blots are shown. Blots 
were quantified and normalised against βActin and are expressed relative to 7am. *P < 0.05, **P 
< 0.01, ***P < 0.001, ns = not significant. 
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3.5.2 Diurnal rhythms of taste sensors in the gastrointestinal tract 
With a clear diurnal expression pattern of hexose transporters anticipatory to 
feeding, we hypothesised that nutrient sensors like the sweet-taste receptor also display 
such a rhythm along the alimentary tract. 
In the tongue, T1R1 shows a significant but small (31%) upregulation at 7pm, 
whereas T1R2, T1R3, αGustducin and αTransducin do not show any rhythmicity (see Fig. 
24a). In the stomach only αGustducin shows a rhythm, with a two-fold induction that 
does not reach significance (p=0.08). In the small intestine, T1R1 shows a trend of 
induction in the duodenum (p=0.09) and the ileum (p=0.19). The sweet-taste receptor 
molecules T1R2 and T1R3 both show a pattern in the proximal regions (Fig. 24b+c). T1R2 
shows ≤2-fold upregulations in the duodenum and jejunum (Fig. 24b). T1R3, on the 
other hand, only demonstrates a significant upregulation in the duodenum, with 38% 
higher mRNA-expression levels. αGustducin shows trends in all tissues, with a two-fold 
induction in the stomach just short of reaching statistical significance (p=0.08). 
αTransducin, on the other hand, only shows an induction of 53% in the duodenum, not 
reaching significance (p=0.08). 
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Fig. 24 Diurnal mRNA expression of nutrient sensors in the murine alimentary tract. Whole 
tongue, stomach, duodenum, jejunum and ileum was dissected from six-week-old CD-1 mice at 
7am or 7pm (n=8 per group) for subsequent quantitative PCR of tas1r1 (T1R1), tas1r2 (T1R2), 
tas1r3 (T1R3), gnat3 (αGustducin) and gnat1 (αTransducin). Values were normalised against 3 
reference genes and relative quantitation was performed using the ddCT method and are 
expressed relative to 7am. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant. 
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Compared to the more established nutrient sensors, a clearer diurnal 
expression pattern appears for the novel sugar sensor SGLT3. SGLT3a shows a 6-fold 
induction in the duodenum and 2.5-fold induction  in the jejunum and a 3-fold induction 
(ns)  in the ileum (Fig. 25a). SGLT3b on the other hand shows a five-fold induction only in 
the stomach, but no rhythm in the small intestine. This clearly demonstrates that 
SGLT3a and SGLT3b have specific roles in the gastrointestinal tract that are different 
from each other. 
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Fig. 25 Diurnal mRNA expression of SGLT3+b in the murine alimentary tract. Whole tongue, 
stomach, duodenum, jejunum and ileum was dissected from six-week old CD-1 mice at 7am or 
7pm (n=8 per group) for subsequent quantitative PCR of slc5a4a (SGLT3a) and slc5a4b (SGLT3b). 
Values were normalised against 3 reference genes and relative quantitation performed using the 
ddCT method and are expressed relative to duodenum at 7am. *P < 0.05, **P < 0.01, ***P < 
0.001, ns = not significant. 
We applied Western blotting to confirm the transcriptomic findings on the 
proteome level. As we demonstrate in Fig. 26, no rhythm for SGLT3 can be detected by 
comparing the protein expression at 7am vs 7pm. 
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Fig. 26 Diurnal protein expression of SGLT3 in the murine small intestine. Whole stomach, 
duodenum, jejunum and ileum was dissected from 11-week-old C57BL/6 mice (n=8 per group) 
for subsequent protein extraction and Western blots of βActin and SGLT3. Representative blots 
are shown. Blots were quantified and normalised against βActin and are expressed relative to 
7am. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant. 
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3.5.3 Diurnal rhythms of gut peptides in the gastrointestinal tract 
The sweet-taste receptor has been shown to be involved in the sensing of 
nutrients and subsequent incretin secretion from enteroendocrine cells (Steinert et al., 
2011). Only very recently has a circadian rhythm of GLP1 been described on the plasma 
protein and transcript level (Gil-Lozano et al., 2014). We therefore studied the diurnal 
expression pattern of the gut peptides CCK, GIP, Preproglucagon (GLP1+2) and ghrelin to 
see if there is a correlation of the observed nutrient sensor diurnal rhythms with 
incretin-expression levels. As demonstrated in Fig. 27, none of the studied genes shows 
a diurnal rhythm. Only the gcg gene that gets translated and cleaved to GLP1 and GLP2 
in the intestine shows a significant 43% induction in the jejunum and a non-significant 
induction of 85% in the duodenum. 
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Fig. 27 Diurnal mRNA expression of gut peptides in the murine alimentary tract. Whole tongue, 
stomach, duodenum, jejunum and ileum was dissected from six-week-old CD-1 mice at 7am or 
7pm (n=8 per group) for subsequent quantitative PCR of slc5a4a (SGLT3a) and slc5a4b (SGLT3b). 
Values were normalised against 3 reference genes and relative quantitation was performed using 
the ddCT method and expressed relative to 7am. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not 
significant. 
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3.5.4 Diurnal rhythm of clock genes in the gastrointestinal tract 
A marked rhythm in the mRNA levels of two canonical clock genes, arntl1 
(BMAL1) and cry2 (CRY2), was found, oscillating in opposing phases, as expected (Fig. 
28). Cry2 is induced at 7pm by 50-400% in all tissues, with the stomach as an exception. 
Arntl1/BMAL1, in contrast, is ~7-fold downregulated at 7pm. This suggests the existence 
of a functional circadian clock in all studied tissues, and that genes including nutrient 
sensors could be under its control. 
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Fig. 28 Diurnal mRNA expression of clock genes in the murine alimentary tract. Whole tongue, 
stomach, duodenum, jejunum and ileum was dissected from six-week-old CD-1 mice (n=8 per 
group) for subsequent quantitative PCR of artnl1 (BMAL1) and cry2 (CRY2). Values were 
normalised against 3 reference genes and relative quantitation was performed using the ddCT 
method and are expressed relative to 7am. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not 
significant. 
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3.5.5 In silico promotor analysis of sugar transporters and nutrient 
sensors 
Clock genes can regulate gene expression by binding to the promotor, within 
the transcript or downstream of it. Clock genes regulate target genes by binding to E-
Box cis-regulatory enhancer sequences. It has been suggested that clock genes bind not 
only the canonical E-Box sequence used by all basic Helix-Loop-Helix transcription 
factors but also an extended E-Box sequence of the form (G/T)G(A/G)ACACGTGACCC. 
We demonstrated diurnal rhythmicity of expression for hexose transporters and 
nutrient sensors, including the sweet-taste receptor and the putative D-Glu sensor 
SGLT3.  We therefore hypothesised that our genes of interest also contain such 
extended E-Box elements.  
We analysed in silico 10,000 bp upstream of the transcription-initiation site of 
hexose transporters, clock genes and the aforementioned nutrient sensors. We found 
the canonical E-Box sequence CACGTG in all genes apart from cry2, gip and gcg (Fig. 29). 
Analysing these sequences for the extended E-Box sequence, we found a near perfect fit 
for arntl1/BMAL1 and slc2a2/GLUT2 (matches highlighted in bold). Slc5a1/SGLT1, 
tas1r1/T1R1, tas1r2/T1R2, tas1r3/T1R3, slc5a4a/SGLT3a, slc5a4b/SGLT3b, ghrl/ghrelin, 
cck/cck and pyy/PYY have at least two nucleotide matches. No E-Box was found for 
cry2/CRY2, gip/GIP or gcg/Preproglucagon in the 10,000 bp upstream of the first exon. 
Several intronic E-Boxes were found for cry2. Directly beside each other are two E-
Boxes, with one of them having a high match to the extended circadian E-Box sequence; 
15,115bp and 15,168bp downstream of the first exon the sequences TGTG-CACGTG-
AGCC and CTGC-CACGTG-CCAG were found. 
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Fig. 29 In silico promotor analysis of hexose transporters and nutrient sensor genes for 
sequences of diurnal E-Box elements. 10,000bp upstream of each translation start were used to 
find E-Box sequences and matching extended consensus sequences are marked in bold. 
These observations suggest that our genes of interest could be potentially 
under the control of clock genes. Directed mutagenesis to study these sequences would 
be needed to evaluate our findings.  
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3.5.6 Gene-expression profiling of tongue tissue at 7am vs 7pm  
3.5.6.1 Analysis of the clock machinery 
In the tongue, we were not able to detect diurnal rhythms for the sweet-taste 
receptor T1R2/3 and only a very small induction for the umami-taste receptor T1R1 (see 
Fig. 24). Yet we showed strong clock activity in the tongue (see Fig. 28). DNA synthesis 
and mitotic activity have been shown to be regulated in a diurnal fashion in the tongue 
(García et al., 2001). Furthermore, glucocorticoids, which display strong diurnal rhythms, 
co-localise with tas1r3 in type-II taste cells and are involved in food entrainment (Peek 
et al., 2012; Parker et al., 2014). Together, this data suggests that genes involved in taste 
preference could be diurnally regulated. We therefore used pooled RNA from 8 mice per 
group and compared the expression patterns on an Affymetrix microarray. 
Looking specifically for the clock-machinery genes and CCGs, we first analysed 
the array for clock genes and important nuclear factors that have gained an important 
role in the emerging model of circadian rhythm as outlined in 3.2.1.  Nuclear factors, 
which are controlled by clock genes and oscillate in a circadian fashion, can affect gene-
transcriptional control. Despite only using pooled samples rather than individual 
samples to save costs, we confirmed our qPCR findings presented earlier, with the 
microarray with cry2 being upregulated and arntl1 being highly downregulated (Fig. 30). 
Furthermore, strong rhythms exist for the clock genes clock, per1 and per3 as 
hypothesised. The nuclear factors presented indicate diurnal rhythmicity with a 
downregulation of RAR-α and high upregulation of Rev-erbβ and RXR-β (Fig. 30). This 
further confirms the diurnal rhythmicity in our tissue samples and suggests the existence 
of CCGs. 
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Fig. 30 Fold changes of clock genes and nuclear factors in the murine tongue. RNA was pooled 
from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA expression was 
compared between 7am and 7pm and fold changes are given. 
3.5.6.2 Analysis of lingual taste receptors 
The sweet-taste receptor did not show a diurnal rhythm, yet we detected high 
clock-gene activity. We therefore manually extracted taste- and nutrient sensing genes 
from the microarray, including sweet-, fat-, umami-, sour- and bitter-taste genes, as well 
as signalling molecules needed for the downstream signal transduction. As expected, no 
regulation of the sweet-taste receptor was detected (Fig. 31). A 6.5-fold and 1.39-fold 
induction was noted for the genes of αTransducin and TRPM5 respectively. TRPM5 is an 
ion channel that is important for the creation of action potentials and shows a 39% 
induction at 7pm. 
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Fig. 31 Fold changes of diurnally regulated taste sensors and necessary signalling molecules. 
RNA was pooled from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA 
expression was compared between 7am and 7pm and fold changes are given. NA= not available 
in microarray chip used. 
The fat receptor cd36 shows a slight increase, whereas ffar2 is downregulated 
by 74% (Fig. 31). The umami-taste receptor mGlu4r was not available in the microarray, 
but tas1r1 shows a 6-fold induction, although we confirmed this finding with qPCR with 
only a slight induction of 31% (p=0.04, Fig. 31).  
It has been suggested that ion channels are involved in sour/H+ sensing. The 
TRPM5-related transporter pkd2l1 was not available in the array, but the epithelial 
sodium-channel ENaC subunits ENaCα+β show a 50% downregulation (Fig. 31). 
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Most striking is the regulation of the T2R family, sensors of bitter tastants. The 
tas2r family consists of at least 30 members (Meyerhof, 2005), but in the applied 
microarray only three genes belonging to this family  were available, namely tas2r105, 
tas2r108 and tas2r119. tas2r105 is 41% upregulated, whereas tas2r108 and tas2r119 
are downregulated by 88% and 289% respectively (Fig. 31). 
We used the GeneGo® ‘bitter taste’ map function to expand the network of 
genes involved in bitter sensing in Taste II taste cells (Fig. 32).  
 
Fig. 32 Bitter-taste map generated by GeneGo®. Shown are a Type-II taste cell for bitter sensing 
and the connection to a Type-III taste cell connecting the taste cell with nerve fibres. 
Demonstrated are intracellular and membrane-bound receptors and signalling molecules 
needed, as well as their interactions with each other. Thermometers indicate intensity of 
up/downregulation. 
Shown is a Type-II taste cell that tastes sweet, umami and bitter and how it 
connects to a Type-III, taste cell which acts as a connector between Type-II cells and 
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nerve fibres and ultimately to the brain. Of note is the second messenger machinery of 
PLCβII and IP3 and the ion channel TRPM5 involved in taste-signal transduction, which is 
regulated in our model.  
Furthermore, of interest is the connection between the Taste-II and Taste-III 
cells. Pannexin1 is located on the Type-II cell membrane and is an ion and small-
molecule channel (e.g. ATP or cAMP) that connects the intracellular with extracellular 
space between cells. Pannexin1 is downregulated, comparing 7am with 7pm. On the 
membrane of the Type-III membrane we find the purinergic signalling-molecule family 
P2X and P2Y (Fig. 32). These large receptor families are activated by nucleotides such as 
ATP, ADP, AMP, UDP and UMP and connect to downstream signals via various G-
Proteins (Abbracchio et al., 2006).  In our array we saw down- or upregulation for p2ry1 
(+1.33), p2ry2 (-1.38), p2ry12 (+1.40), p2ry14 (-1.18). For the P2X family we were able to 
detect two-fold downregulation for p2rx1 and p2rx2, whereas p2rx7 was three-fold 
downregulated. 
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3.5.6.3 Analysis of lingual gut peptides 
Recent findings have shown that many of the known gut peptides such as GLP1, 
ghrelin and CCK can also be detected in lingual taste buds (Herness et al., 2002; Gröschl 
et al., 2005; Shin et al., 2008). Oral PYY has now been found to be involved in reducing 
food intake (Acosta et al., 2011). As some of the nutrient receptors are regulated in this 
study, we hypothesised that this also affects lingual peptide-hormone levels. Indeed, the 
expression of gcg, pyy, ghrl and cck was downregulated, whereas gip expression was 
upregulated (Fig. 33). 
 
 
Fig. 33 Fold changes of diurnally regulated gut peptides in the murine tongue. RNA was pooled 
from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA expression was 
compared between 7am and 7pm and fold changes are given.  
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3.5.6.4 Circadian-rhythm network map 
Using the automated ‘circadian rhythm’ function in GeneGo, we were able to 
visualise a network map of clock genes and CCGs (Fig. 34). The interaction between clock 
genes (e.g. CRY1+2, PER1-3, CLOCK, BMAL1) and nuclear factors (e.g. Rev-erbβ and ROR-
α) is clearly visible in the nucleus. Also shown are the targets and affected genes of the 
clock machinery, especially in the cytosol and plasmalemma. 
 
Fig. 34 Network map built with the ‘Circadian rhythm’ function in the GeneGo software. Shown 
are nuclear, intracellular and membrane-bound clock genes and clock-affected genes, as well as 
their interactions with each other. Thermometers indicate intensity of up/downregulation. 
Of interest is the regulation of PACAP and its membrane-bound receptor. 
PACAP has been found to stimulate enterochromaffin-like cells in the intestine and CCK 
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secretion in the L-cells (Chang et al., 1996). We found a 64% upregulation for PACAP and 
2-fold downregulation for the PACAP receptor (see membrane in Fig. 34).  
Also notable is the high downregulation of the NMDA receptor (top left corner, 
Fig. 34). It has been suggested that the NMDA receptor is an alternative L-glutamate 
receptor for umami taste (Lin & Kinnamon, 1999). In the map, all NMDA receptors are 
combined as ‘NMDA receptor’. Several genes were identified in this group and extracted 
from the microarray, including grin1, grin2a, grin2b and grin2c, with downregulations of 
23-fold, 0.4-fold, 3-fold or 5-fold respectively. 
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3.5.6.5 Top 10 diurnally regulated genes  
To further study the phenotype we manually extracted the top 10 regulated 
genes (enrichment analysis of the dataset can be seen in appendix I). The top 10 
upregulated genes either are involved in immunity (dock2, h2-k1, vcam1, hivep3) or 
adrenergic-nerve signalling (ankrd1, adrb3) or are transcriptional regulators (dbp, tead2, 
per3), and range with upregulations between 7- and 22-fold (Fig. 35). All of the 
downregulated genes are enzymes (proteases, carbohydrases, lipases), and have very 
high downregulations between 300- and 64,000-fold.   
 
Fig. 35 Fold changes of the top ±10 diurnally regulated genes in the murine tongue. RNA was 
pooled from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA expression 
was compared between 7am and 7pm and fold changes are given and sorted by fold change.   
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3.6 Discussion 
The alimentary tract is the first barrier in contact with nutrients. It has evolved 
intricate mechanisms to sense nutrients and react to nutrient load. Yet the body not 
only reacts to nutrients upon stimulation but is also able to prepare anticipatory to 
feeding to optimise nutrient uptake. This is governed by central and peripheral clock 
machinery. Our modern diet and eating behaviour have changed since the Palaeolithic, 
and this could implicate a mismatch of physiologic mechanisms, leading to the 
increasing prevalence of metabolic diseases. Circadian rhythmicity of hexose 
transporters was demonstrated many years ago (Corpe & Burant, 1996), but a rhythm 
for GLP1 has only been shown very recently (Gil-Lozano et al., 2014). GLP1 secretion 
from L-cells is controlled by the sweet-taste receptor and its downstream signalling 
machinery, including αGustducin (Jang et al., 2007). We therefore hypothesised that 
nutrient sensors like the sweet-taste receptor also show diurnal rhythmicity anticipatory 
to feeding in the small intestine, but also in the tongue and stomach, and regulate gut 
peptide secretion. To test this hypothesis, we used wild-type mice fed a normal chow 
diet and compared the gene and protein expression at 7am and 7pm. 
The sugar transporters SGLT1, GLUT2 and GLUT5 and the clock genes CRY2 and 
BMAL1 demonstrated a clear diurnal pattern of expression at the mRNA level, and we 
also confirmed this on a proteomic level for GLUT2. We were not able to show diurnal 
expression for the sweet-taste receptor T1R2/3 and only a very small induction for the 
umami-taste receptor T1R1. For the first time a diurnal rhythm of expression was seen 
for the putative sugar sensors SGLT3a and SGLT3b. The gut peptides GLP1, CCK, GIP and 
ghrelin did not display diurnal rhythmicity in the gastrointestinal tract, but showed 
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rhythmicity in the tongue. Clock genes showed a strong rhythm and we were able to 
identify E-Box elements necessary for transcriptional regulation in gene promotors of 
most genes of interest. Gene expression profiling using a microarray on tongue RNA 
revealed bitter taste receptors, especially, to be highly regulated as were new processes 
including adrenergic signalling and immunity. 
3.6.1 Sugar transporters, clock genes, nutrient sensors & gut peptides 
The distinct circadian rhythmicity of nutrient transporters (Corpe & Burant, 
1996), insulin and GLP1 secretion (Boden et al., 1996; Gil-Lozano et al., 2014) led us to 
study temporal changes of expression for nutrient sensors, gut peptides and clock gene, 
and also to study promotor sequences of genes of interest in silico. Despite the clear 
rhythms of clock genes cry2 and arntl1 in all tissues, the sweet- and umami-taste 
receptors displayed very little diurnal regulation in the tongue and gut. SGLT3a and 
SGLT3b, on the other hand, showed a clear pattern. SGLT3a, which does not transport 
sugar has hence been suggested that it is a sugar sensor (Barcelona, 2012), displayed a 
marked upregulation of expression at 7pm (compared to 7am) in the duodenum and 
jejunum. SGLT3b, a high-affinity D-Glu transporter, was significantly upregulated in the 
stomach at 7pm compared to 7am. This is the first evidence that SGLT3a and SGLT3b 
exhibit a diurnal rhythm of expression in the gastrointestinal tract. These findings add 
evidence to the theory that SGLT3a and SGLT3b are two distinct proteins with different 
roles. 
SGLT1 expression is under the control of clock genes (Balakrishnan et al., 2010). 
SGLT1 has high gene- and protein-sequence similarity with SGLT3a and SGLT3b. Not only 
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did our in silico promotor study find circadian E-Box elements for genes that have been 
shown to have a clear circadian rhythm (e.g. GLUT2), but we were also able to find these 
E-Box elements in the clock gene arntl1, nutrient sensors including the sweet-taste 
receptor T1R2/3 and SGLT3 and the gut peptides ghrelin, CCK and PYY. Experimental 
evidence has shown that clock genes directly regulate the  expression of the 
oligopeptide transporter PEPT1 and the Na+/H+ exchanger NHE3 (Rohman et al., 2005; 
Saito et al., 2008).  
Our data suggest that the genes analysed in our study can potentially be under 
clock-gene control via circadian E-Boxes. Further exploration and functional promotor 
studies are needed to establish exact transcriptional control mechanisms by clock genes. 
Many new sequencing technologies like ‘nascent-Seq’ have been developed to allow 
direct and accurate measurement of gene activity and post-transcriptional modifications 
which could be potentially be used for further research (Kojima & Green, 2015). Also, 
many more mechanisms besides E-Boxes exist to control circadian expression. SGLT1 has 
been shown to be regulated by PER1 in an E-Box-independent fashion (possibly by acting 
on other clock genes that bind to non-E-Box elements in the promotor) (Balakrishnan et 
al., 2012). Furthermore, micro RNAs (miRNAs) and long non-coding RNAs (lncRNAs) have 
been found to be important regulators of mRNA survival and subsequent translation of 
clock genes (Lee & Bartolomei, 2013; Du et al., 2014). Lee and Bartolomei suggest that 
up to 30% of CCGs undergo miRNA-mediated regulation. An array of post-translational 
modifications have also been implicated in the regulation of CCG protein expression 
(Kojima & Green, 2015).  
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SGLT3 was duplicated to SGLT3a and SGLT3b in rodents and hence has high 
similarity with SGLT3a and SGLT3b. Yet our cephalocaudal data suggests that the gene 
expression of SGLT3a and SGLT3b is regulated differently and highly specific to 
accommodate two different roles in the gastrointestinal tract, as discussed earlier. Our 
work on the diurnal rhythmicity of both genes further suggests two different functions 
in the gastrointestinal tract and are interesting in the context of metabolism and its 
dysregulations. In today’s society meal timing and patterns have changed (most evident 
in shift workers) and such changes have been suggested to increase the risk for 
metabolic diseases (Pan et al., 2011). Polymorphisms in circadian regulatory genes have 
been linked to obesity and type 2 diabetes (Scott et al., 2008). 
We demonstrated that SGLT3b is highly upregulated anticipatory to feeding in 
the evening. An interesting study found, using pyloric cuffs to prevent gastric emptying, 
that a post-gastric (i.e. intestinal) sensor is necessary for glucose-induced gastric ghrelin 
suppression (Williams et al., 2013).  Yet their study protocol takes many hours and it 
stands to reason that the researchers performed their experiments during the day. 
Based on our findings, we suggest that the study by Williams et al. did not find a sensor 
because it had not yet been expressed. This is interesting as it could be implicated in 
dysregulated feeding behaviour. SGLT3 has been shown to be important for glucose 
sensing in the portal vein. Strategically expressed on neurons in the wall of the vein, it 
can relay messages about the nutrition status to the hypothalamus to suppress appetite 
(Mithieux, 2014). It could be speculated that gastric SGLT3b has a similar role, but if food 
is ingested during times of the day when expression is low (i.e. humans in the night, 
rodents during the day), satiety signals to the brain are not as strong which can lead to 
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overeating and over time induce obesity. It would be interesting to repeat the study by 
Williams et al. in the evening time to test this. 
SGLT3b is also higher expressed in the distal small intestine, which suggests it 
could be involved in the ileal-brake phenomenon (Spiller et al., 1984; Maljaars et al., 
2008). It has been shown that incretin responses are blunted in diabetic/obese patients 
(Nauck et al., 1986; Lindqvist et al., 2005) and GLP1 has been demonstrated to have a 
circadian pattern of expression only recently (Gil-Lozano et al., 2014). The regulation of 
GLP1 secretion is taste-receptor-dependent and has been linked to SGLT3 (Lee et al., 
2015). If clock mechanisms are disturbed it is also possible that the diurnal expression of 
SGLT3b is disturbed. When D-Glu arrives in the ileum, but is less sensed by SGLT3b, the 
incretin response could be attenuated. The incretin response is important for insulin 
secretion and satiety signalling to the brain, as well as decreasing gastric motility and 
emptying. A blunted incretin response due to decreased SGLT3b mediated sensing, 
hence, could be a factor leading to the metabolic dysregulations seen in groups such as 
shift workers. 
In contrast to SGLT3b, SGLT3a displayed high diurnal regulation in the proximal 
small intestine, which is also where luminal sugar concentrations are highest. Luminal D-
Glu induces functional feedback via vagal nerve and gut peptide pathways (Young, 
2011a),  including the regulation of gastric emptying, transport function and food intake 
(Raybould & Hölzer, 1992; Horowitz et al., 1993; Pilichiewicz, 2007). It can be speculated 
that either optimal eating times exist when SGLT3a is highly expressed or that if clock 
mechanisms become disturbed and hence SGLT3a’s diurnal rhythmicity becomes 
blunted, intestinal feedback mechanisms upon luminal stimulation are also blunted. This 
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in turn could then affect intestinal motility, insulin secretion and satiety and lead to 
metabolic disease. 
The rhythms in the central and peripheral clocks are partly entrained by the 
FEO, which in turn are guided by intraluminal nutrient-concentrations and gut peptide 
levels (Balakrishnan et al., 2008; Pan & Hussain, 2009). As outlined above, we speculate 
that SGLT3a+b play major roles in the detection of gastrointestinal sugar concentrations 
crucial for the entrainment of clock systems, but are also implicated in metabolism and 
feeding. It would be of interest to study if the expression and diurnal rhythmicity of 
SGLT3 is dysregulated in metabolic disease. 
Furthermore, humans only have one form of SGLT3. Rodents are adapted to a 
diet high in carbohydrates which could explain the gene duplication. Potentially this 
means that humans are maladapted to a diet based on carbohydrates (Last & Wilson, 
2006). Further research on SGLT3 in humans is needed. 
3.6.2 Gene expression profiling in the tongue 
In the tongue we demonstrated strong clock-gene activity, but no diurnal 
rhythmicity for the sweet- and umami-taste receptors. Yet the high activity of clock 
genes suggests the presence of CCGs. We therefore used microarrays for gene-
expression profiling to identify diurnally controlled genes related to nutrient sensing.  
Dissecting the different nutrient sensor groups, we were able to identify the 
bitter-taste sensor group to be highly regulated. The T2R group consists of at least 40 
receptors. Bitter tasting provides an important protective function, as toxic foods are 
generally bitter and the ability to detect these compounds at low thresholds gave an 
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evolutionary advantage (Callaway, 2012). We speculate that an anticipatory expression 
of such bitter-taste chemosensors ensures that potential toxic foods are readily 
detected when the animal starts eating.  A broader study approach of more T2R genes 
will help understand better why certain bitter sensors are upregulated and some 
downregulated anticipatory to feeding. 
The cephalic response to nutrient intake is gaining more importance as a player 
in metabolism, including postprandial glycaemia (Ahrén & Holst, 2001; Zafra et al., 2006; 
Power & Schulkin, 2008). Gut peptides have been shown to be expressed in the tongue 
to mediate local and systemic effects. We therefore evaluated the diurnal regulation of 
gut peptide expression in the tongue. We were able to identify strong diurnal rhythms 
for gcg, gip, pyy, ghrl and cck. This highlights the potential importance of gut peptides 
outside of the gastrointestinal tract and potential involvement in feed-forward 
mechanisms from the oral cavity to the distal alimentary tract. These anticipatory 
mechanisms are potentially involved in preparing the alimentary and especially the 
gastrointestinal tract for incoming food to enable optimal nutrient assimilation. 
However, whilst such a pattern would be conducive to maximising nutrient intake in 
times of scarcity it could mean a potential ‘maladaptation’ to today’s food availability. 
Using the microarray, we were able to identify several interesting groups of 
genes with diurnal rhythmicity: 
The NMDA receptor group was highly downregulated. The NMDA receptor is an 
L-glutamate receptor and ion-channel protein that is found in nerve cells. Activated by a 
ligand like L-glutamate, it leads to the influx of positively charged ions. In an EEC model 
it has been shown that the NMDA receptor is involved in gut peptide secretion 
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(Fukunaga et al., 2010). In the tongue, it has been suggested that the NMDA receptor 
acts as an ionotropic umami-taste receptor beside the classic metabotropic receptors 
T1R1/3 and mGlu4R (Lin & Kinnamon, 1999). Our data suggests that the NMDA receptor 
could potentially be involved in lingual gut peptide secretion, which is important for 
feed-forward mechanisms. 
We were also able to identify genes involved in paracellular signal transmission. 
We identified pannexin1, which is a channel for second messengers like cAMP, and 
receptors for such nucleotides (p2x and p2y family) on neighbouring cells. This could be 
important for the signal transduction from taste cells to nerve cells with Taste-III cells 
lying in-between (Yoshie, 2009). These results need to be confirmed with transcriptomic 
and proteomic techniques and in situ experiments will help identify exact location of 
expression.  
Manually selecting the top 10 up- and downregulated genes opened up new 
avenues for further research. The top 10 upregulated genes were either adrenergic 
nerve-signalling (ankrd1, adrb3), immune processes (dock2, h2-k1, vcam1, hivep3) or 
transcription factors (dbp, tead2, per3). dbp and per3 are actually clock genes, and are 
highly involved in circadian rhythmicity (Stratmann et al., 2012).  
The regulation of the adrenergic nerve-signalling mechanisms is interesting in 
combination with our findings of the NMDA receptor and transcellular signalling of 
pannexin1. Even if taste receptors are not regulated diurnally, but downstream 
signalling pathways are, the signals translated to the brain could potentially display 
rhythmicity. Indeed, studies have shown diurnal rhythmicity for sweet preference 
(Nakamura et al., 2008). Better understanding of the mechanisms underlying these 
Chapter 3: Diurnal regulation of nutrient sensors along the alimentary tract 
 
- 118 - 
observations are important for better understanding the cephalic phase of digestion 
with respect to appetite, satiety and obesity. 
A recent study also revealed how adrenergic nerve-signalling is important for 
signal circadian recruitment of immune cells to peripheral tissues, including skeletal 
muscle (Scheiermann et al., 2012). vcam1, especially, was pointed out in this study as 
this ‘vascular cell-adhesion molecule-1’ is necessary for leukocyte arrest on endothelial 
cells and subsequent extravasation into tissue. Based on this study and our results, we 
suggest that leukocyte infiltration mediated via adrenergic signals also takes place in the 
tongue. This could potentially help fend off infectious agents, as more contact with 
bacteria and viruses is made during times of high activity such as food finding and 
eating. 
The top 10 downregulated genes are all enzymes (proteases, carbohydrases, 
lipases). Most of them (try4, pla2g1b, cpb1, cpa1, ctrb1, clps, and ela3) are highly 
specific to the pancreas. Oral enzymes such as amylase and lipase are important for the 
cephalic response of insulin secretion (Zafra et al., 2006). It would be expected to 
measure higher expression anticipatory to feeding rather than downregulation, as we 
saw in our experiment. This would help start digestion in the oral cavity and make it 
possible to sense exact nutrients in the food and prepare the rest of the digestive tract 
accordingly. As we used crude tongue tissue including muscle, epithelium, nerves and 
blood vessels, exact localisation of where these genes are expressed would help to shed 
light on the exact mechanism. Co-localisation with taste papillae would be interesting 
and requires further research. 
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The automatic ‘circadian map’ function in GeneGo™ enabled us to analyse new 
genes involved with clock genes. PACAP and its receptors were identified. PACAP has 
high similarity to the vasoactive intestinal peptide (VIP) and was 64% upregulated. 
PACAP binds to the VIP and PACAP receptor and stimulates adenylate-cyclase function. 
VIP has been found to be expressed in type-II taste cells in the tongue, and to be co-
localised with αGustducin. Type-II cells also express the sweet-, bitter- and umami-taste 
receptors, which need αGustducin for signal transduction. VIP and PACAP share similar 
functions regarding metabolism and gastrointestinal function and VIP knockout mice can 
substitute the loss of VIP with PACAP (Winzell & Ahrén, 2007). One of PACAP’s effects is 
to stimulate enterochromaffin-like cells in the intestine, and it has been shown to 
stimulate CCK secretion in the L-cell model,  STC-1 (Chang et al., 1996). The high 
similarity to VIP and PACAP’s involvement in intestinal nutrient sensing suggest further 
research on its role in the tongue. We speculate a potential involvement of PACAP in the 
cephalic phase similar to that of the gut peptides as discussed earlier. 
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3.7 Limitations of the study 
Despite the vast amount of novel findings, several limitations appear in our 
study. We obtained our stomach samples frozen in tubes from a collaborator, and only 
dissected ~15 mg of material from the whole tissue block. We were not able to 
determine from which region the extracted RNA came. This is important, as the stomach 
has different regions with distinct functions, cell populations and mRNA expression-
profiles (Young et al., 2009). 
We were able to show matching diurnal rhythms for GLUT2 at the mRNA and 
protein levels. Unfortunately, we were not able to show diurnal rhythmicity for the 
sweet-taste receptor at the mRNA level or confirm our mRNA findings for SGLT3 on the 
protein level. A recent paper on circadian rhythms in the liver was able to show that 
transcriptomic rhythms do not always match proteomic rhythms and also showed how 
rhythms in the proteome do not necessarily stem from circadian regulated transcripts 
(Mauvoisin et al., 2014). This can be explained by the vast amount of transcriptional and 
post-transcriptional, as well as the various post-translational mechanisms, that alter 
mRNA and protein stability as discussed earlier. Furthermore, protein expression tends 
to slightly lag behind mRNA expression as seen for hexose transporters (Houghton et al., 
2006). Generally, diurnal rhythms of the proteins also seem to be less clear, due to the 
sensitivity limitations of Western blot assays. Again, more time points will be needed to 
confirm our findings. In addition, proteins were extracted from tissues from other 
animals due to lack of tissue material. Proteins were taken from C57BL/6 inbred mice 
instead of the CD-1 outbred strain used for gene expression. We did run test qPCRs on 
those tissues to ensure diurnal rhythmicity, but many studies have shown differences in 
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study outcomes when comparing mouse strains (e.g. Barone et al., 1993). It cannot be 
excluded that differences between these two animal strains exist on a protein level, 
despite the same gene-expression results. 
Furthermore, we unfortunately only had two time points available for our 
study. Many other studies show at least four time points, which make it possible to see a 
clearer circadian rhythm. Our two time points might be exactly when the oscillation is at 
the same level, and we therefore might have missed the diurnal rhythm. Moreover, 
even though the clock genes showed a clear rhythm other studies with many more time 
points show that maximum peaks for clock genes are just a few hours into the light and 
dark phases and not at the beginning, like in our study (Lamia et al., 2008; Takahashi et 
al., 2013). As the clock genes are generally higher induced than clock-controlled genes, 
this could explain why we see rhythms for clock genes, but not for the umami- and 
sweet-taste receptors. A repeat of the study with more time points is needed. 
We were able show a slight diurnal rhythm for gcg in the jejunum. Gil-Lozano et 
al., 2014 who published evidence for a circadian rhythm of GLP1 only in late 2014, 
despite many other studies having failed to do so, state that identical nutrient 
composition and caloric loads need to be ensured, as otherwise the rhythm gets 
obscured. Furthermore, the paper also shows gcg gene expression and shows peaks 
later at night during the dark phase. Our two time points, 7am and 7pm, would have 
barely shown a rhythm in their study. Again, more time points would have been useful, 
and blood GLP1 levels would have been instrumental. Later and more time points would 
also be beneficial for the other gut peptides (GIP, CCK, ghrelin), as we also suspect a 
diurnal rhythm.  
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3.8 Conclusions 
This study was able to confirm findings of diurnal rhythms of expression of 
intestinal sugar transporters and clock genes shown from previous studies. However, we 
demonstrated for the first time that the novel sugar sensor SGLT3 displays diurnal 
rhythmicity in the stomach and small intestine tract at the mRNA, but not protein level. 
We suspect that the novel sugar sensor SGLT3 is expressed in a circadian, oscillatory 
pattern at the mRNA and protein levels and is under transcriptional regulation by clock 
genes, which are themselves entrainable by food within the intestinal lumen. SGLT3 may 
therefore play an important role in the FEO mechanism. The full function of SGLT3a+b is 
currently not clear, but the findings of this study suggest a role in the regulation of 
gastrointestinal function, such as sugar uptake and gut hormone secretion, as well the 
control of food intake by the brain. We also showed diurnal rhythmicity of expression of 
lingual gut peptides potentially involved in feed-forward mechanisms to the gut.  
Our findings may be implicated in metabolic diseases such as diabetes and 
obesity. Better understanding of the underlying physiology will help optimise meal-
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CHAPTER 4 
EFFECTS OF METABOLIC SYNDROME ON 
NUTRIENT-SENSOR EXPRESSION LEVELS IN THE 
ALIMENTARY TRACT AND INTESTINAL FUNCTION  
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4 EFFECTS OF METABOLIC SYNDROME ON NUTRIENT-SENSOR 
EXPRESSION LEVELS IN THE ALIMENTARY TRACT AND INTESTINAL 
FUNCTION 
4.1 Summary 
Background The prevalence of metabolic syndrome is increasing at an alarming rate. Yet 
there is a lack of understanding of the role of the alimentary tract in the development of 
metabolic syndrome. We hypothesised that macronutrient sensors and gut peptides are 
dysregulated in metabolic syndrome.  
Aims: The aim of the study is to identify changes in gene expression affecting the 
function of the alimentary tract in a mouse model of metabolic syndrome induced by a 
chronic high-sucrose diet (HSD). 
Methods To test our hypotheses, we studied gene-expression levels in a rodent model 
of metabolic syndrome. Mice had free access to chow, but HSD mice were given ad 
libitum access to sugar-rich condensed milk for six weeks. We applied gene-expression 
profiling techniques to further study genes in the murine affected by the high-sucrose 
feeding. 
Results Mice were hyperphagic, had higher weight and became diabetic with high 
fasting-glucose in response to the chronic HSD. SGLT3a and SGLT3b were downregulated 
in the small intestine. Jejunal CCK and gastric ghrelin expression was increased. 
Furthermore, the microarray revealed a high regulation of inducible nitric oxide 
synthase (iNOS) in the tongue and small intestine, and also a high induction of 
inflammatory processes. 
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Conclusions Taken together, these data demonstrate a dysregulation of gastrointestinal 
nutrient-sensor and gut peptide expression and an inflammatory state in metabolic 
syndrome, suggesting such disturbances may be important in the development of diet-
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4.2 Background 
The aetiology and pathophysiology of metabolic syndrome are a vast and 
complex interplay between genetic and environmental factors (Kaur, 2014). Yet the 
underlying issue and cause is the overconsumption of food and reduced activity levels, 
causing obesity. The hyperplasia and hypertrophy of fat cells leads to increased 
production of cytokines including TNFα, which leads to tissue inflammation and a 
cascade of consequences including macrophage infiltration (Xu et al., 2003). The local 
inflammatory state leads to systemic chronic inflammation, which ultimately drives 
insulin resistance (Hotamisligil, 1999). The effects metabolic syndrome, obesity and type 
2 diabetes can have on tissues are extensive. Furthermore, what is causative to the 
phenotype or a consequence of another dysregulated system in the body can be hard to 
dissect. The influences and mechanisms in adipose, muscle, liver, brain and pancreatic 
tissues are well studied. The role in the aetiology of metabolic syndrome, but also the 
consequences on the alimentary tract, are less studied, but are becoming clearer. The 
sugar transporters GLUT2 and GLUT5 have been shown to be increased in the small 
intestine of diabetic rats (Corpe et al., 1996). GLUT2 has also been shown to be 
increased in intestinal brush-border membranes of obese patients (Ait-Omar et al., 
2011). This observation has been explained to be potentially due to the loss of insulin-
mediated GLUT2 internalisation (Tobin et al., 2008). This evidence suggests that the 
small intestine can contribute to postprandial hyperglycaemia, which is implicated in 
cardiovascular disease and type 2 diabetes.  
Furthermore, it has been shown that the incretin response via GLP1 is blunted 
in type 2 diabetes (Nauck et al., 1986). GLP1 is important for inhibiting gastrointestinal 
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secretion and motility, especially gastric emptying (Wettergren et al., 1993; Nauck et al., 
1997). The physiological role of GLP1 is hence the control of the delivery of digestive 
chyme to the proximal intestine and insulin secretion stimulated by insulinotropic 
nutrients mediated via incretins (Layer et al., 1995). Not only does GLP1 exert its effects 
via endocrine pathways, but the nervous system seems to be highly involved. Several 
observations speak for this. First of all, GLP1 is degraded rapidly within minutes due to 
the high activity of DPPIV, which may only allow action locally in the gut. Furthermore, 
intraportal infusion of GLP1 caused higher impulse activity in vagal nerve-trunks 
(Nishizawa et al., 1996). These impulses might be transmitted to the pancreas and also 
nucleus of the solitary tract and hypothalamus, linking the gut with the brain 
(Nakabayashi et al., 1996; Nakagawa et al., 2004). GLP1 inhibits appetite via these routes 
or directly in the brain, and it has been shown that in obesity GLP1 secretion is highly 
reduced after meal ingestion compared to lean controls (Ranganath et al., 1996). The 
loss of appetite-inhibition might then start a vicious circle, aggravating the uncontrolled 
weight gain.  
Ghrelin, a hunger hormone produced and secreted from the stomach, has also 
been shown to be dysregulated in metabolic syndrome. The exact mechanisms for its 
regulation are not clear, but it has been suggested that a post-gastric sensor is needed 
to decrease its release upon eating (Williams et al., 2013). Duodenal αGustducin and the 
fat receptor GPR120 have been shown to be involved (Janssen et al., 2012; Gong et al., 
2014). Studying the stomachs of obese patients revealed that gustatory cells, positive 
for TRPM5, were twice as numerous in stomachs of obese patients (Widmayer et al., 
2012). The authors also found that neighbouring ghrelin-producing cells were also more 
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abundant. Similarly, in a high-fat-fed mouse model it was found that the fat receptor 
GPR120 was highly increased in the stomach, as were ghrelin- and gastrin-producing 
cells (Widmayer et al., 2015). Despite these observations in rodents, it has been 
observed that in obese humans ghrelin blood levels are actually lower (Tschop et al., 
2001). Widmayer et al. suggest though that the higher number of ghrelin-producing cells 
is a compensatory response to the higher number of gustatory cells, as long-chain fatty 
acids have been shown to inhibit ghrelin production via GPR120 (Lu et al., 2012; Gong et 
al., 2014). Young et al. (2009) showed no change of TRPM5, T1R2 and T1R3 expression in 
duodena of type 2 diabetic patients, but demonstrated an inverse correlation to blood-
glucose concentrations, although results were not significant. GLP1 release from 
intestinal L-cells is sweet-taste-receptor dependent (Gerspach et al., 2011).  
Furthermore, iNOS has been shown to be enriched in gastric tufted cells, where 
it has been suggested to be an alternative to cellular PLCβ2 signalling, as well as 
stimulating interstitial nerve endings and neighbouring EECs, blood vessels and epithelial 
cells (Hofer et al., 1996). The sweet-taste receptor is also expressed in the pancreas, 
where dysregulated inducible NO synthase (iNOS) has been shown to play a role in the 
impairment of βcell function, ultimately leading to defective insulin secretion (Qader et 
al., 2003; Hegyi & Zoltán Rakonczay, 2011). NO released by lingual taste buds has been 
shown to act as a paracrine signalling-molecule that results in the depolarisation of taste 
cells, which leads to a nerve signal (Kretz et al., 1998; Lindemann, 2001; Nakamura et al., 
2005).  
As outlined earlier, it has been suggested that added sugars from SSBs are one 
of the factors responsible for the epidemic of metabolic syndrome. A recent study in 
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mice has shown how a diet high in sucrose increased total caloric intake, enhanced liver 
triglyceride accumulation and increased intestinal GLUT2, GLUT5 and CCK mRNA 
expression levels (Ritze et al., 2014). Hexose-transporter expression is potentially under 
the control of gut peptides from neighbouring EECs (Margolskee et al., 2007).  
Based on these observations, we hypothesised that nutrient-sensor, gut-
peptide and iNOS expression is dysregulated in the alimentary tract of mice with 
metabolic syndrome. We therefore used a mouse model chronically fed with a diet high 
in sucrose to induce metabolic derangements.  
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4.3 Chapter Overview – Effects of metabolic syndrome on 




Identify the effects of high-sucrose feeding on the metabolic phenotype and small-
intestinal gene expression. 
Hypothesis 
A chronic diet high in sucrose leads to type 2 diabetes mellitus and changes nutrient-
sensor and gut-peptide expression levels in the small intestine. 
Objectives 
 Characterise the phenotype and metabolic profile of chronically high-sucrose-
fed mice 
 Study nutrient-sensor, gut-peptide and signalling gene-expression in the 
alimentary tract of high-sucrose-fed mice 
 Evaluate the gene-expression profile via microarrays in the small intestine 
 Evaluate the effects of chronic sucrose exposure in an in vitro enterocyte model, 
Caco-2/TC7 cells 
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4.4 Materials & Methods 
4.4.1 Laboratory animals & study protocol 
Sixteen C57BL/6 juvenile male mice (28 days of age) were obtained from 
Charles River, UK, and were randomly assigned to two groups (n = 8); either a high-
sucrose (HSD) or a control diet. Mice were weighing 16.5 ±0.59 g and 16.5 ±0.39 for the 
control group and the HSD group, respectively. The animals were individually housed in 
cages with wood-chip bedding (Utemp1284 cages, Techniplast, UK; Aspen-wood chips, B 
and K Ltd) under controlled temperature (20–22˚C) and humidity conditions (45–65%) 
with a 12 h light/dark cycle.  
All animals were acclimatised for one week with free access to the control diet 
(2% corn oil pellets) and water. After the acclimatisation period, the control mice were 
continued on the control diet and the HSD mice were given free access to light 
condensed milk (LCM) (Carnation milk, Nestlé, UK) in addition to the control diet 
(AIN93G) for a period of six weeks (see Table 5 for diet composition). As mice 
completely switch to LCM only, 1% corn oil was added to LCM to make the fat-to-
carbohydrate ratio similar to the control diet. This diet is considered a low-fat diet, as fat 
content is below 4.5%. 
Throughout the intervention, body weights, chow intake and LCM consumption 
were recorded daily. Animal husbandry was carried out by Prof Victor Preedy and Dr 
Peiying Sim and tissue isolation by Dr Christopher Corpe. 
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Table 5 Macronutrient composition of control pellet chow and LCM 
 2% corn oil chow       LCM+ 1% corn oil 
 g / 100 g kcal/100 g g/100 g kcal/100 g  
Total carbohydrate 68 255 59.5 223.1  
 Starch 58 217.5 0 0  
 Sucrose 10 37.5 47.3 177.4  
 Lactose 0 0 12.2 45.7  
Fat 2 18 1.2 10.8  
Protein 20 80 9.3 37.2  
Total  100 353 100 271.1  
 
4.4.2 Serum biomarker analysis 
After the six-week dietary intervention, all animals were fasted overnight to 
minimise the variation in the time between the last food intake and blood and tissue 
collection. All animals were sacrificed via decapitation. Blood samples were collected 
and whole blood was processed to obtain serum. Serum glucose, insulin, cholesterol 
and triglycerides were analysed using Siemens Healthcare Diagnostics Ltd kits, 
following the manufacturer’s instructions. Non-esterified fatty acids (NEFA) were 
analysed using a kit by WAKO Chemicals. Serum analysis was carried out by Prof 
Victor Preedy and Dr Peiying Sim. 
4.4.3 Transcriptomic analysis 
RNA extraction, cDNA synthesis, qPCR and Microarray analysis were performed 
as described in section 3.4. Statistical analysis of qPCR data was performed as described 
in section 3.4.5. 
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4.4.4 Caco-2 experiments 
Caco-2/TC7 cells were grown as outlined in section 2.4.1. After 18 days of 
culture in 25 mM D-Glu, cells were split into two groups (n = 6/group). One group was 
switched to 25 mM sucrose, whereas the other group was continued in 25 mM D-Glu. 
Media was glucose-free DMEM equivalent to ‘growth media’ including FBS, MEM, 
Pen/Strep as outlined earlier, but 25 mM D-Glu or sucrose was added. After three days 
of culture in sucrose or D-Glu, media was either collected for nitric oxide measurements 
(see 4.4.5) or RNA harvested as outlined for further transcriptomic evaluation using 
qPCR (see 2.4.3).  
4.4.5 Nitric-oxide detection 
Cell media was harvested at day 21 from Caco-2/TC7 cells as outlined in section 
4.4.4. Media (0.5 ml) was diluted 1:3 in reaction buffer and filtered using Millipore 
10,000 MWCO filters (Fisher Scientific, Leicestershire, UK) by centrifugation for 5 min 
with 14,000 × g on an Eppendorf 5417R centrifuge. Filtrate was harvested and nitric 
oxide determined using a ‘Nitric Oxide (total), detection kit’ following the supplied 
protocol (Enzo Lifesciences, Exeter/UK). 
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4.5 Results 
4.5.1 High-sucrose diet: Food intake & calorie consumption 
 
Mice had free access to either the control diet or control pellet chow with free 
access to LCM (HSD). The control diet consisted of pellet chow including 2% corn oil and 
the HSD group had access to the control pellet chow with free access to LCM including 
1% corn oil. Food and calorie intake was calculated daily over six weeks of the 
experiment, including the acclimatisation week. As seen in Fig. 36, mice completely 
neglected pellet chow when LCM was offered. The higher palatability of LCM led to 
increased consumption of food per day than in the control group with a daily average of 
3.15±0.07 g/day vs 4.88±0.06 g/day for the control group and HSD group, respectively. 
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Fig. 36 Mean daily food intake (g·day−1) in C57BL/6J mice during prolonged HSD or control 
feeding. Mice at 4 weeks of age were caged singly, acclimatised on the control diet for 1 week 
and then weaned on either the control diet or the HSD. Daily consumption of pellet chow and 
additional LCM in the HSD group were measured. Data presented are means ± SEM (n = 8). 
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The increased food intake results in higher energy intake over the course of the 
study (Fig. 37a). Mean daily intake was of 11.56±0.15 vs 13.42±0.16 kcal/day (p ≤0.001) 
for the control group or HSD group respectively (Fig. 37b). The higher energy 
consumption led to increased body weights over the six week experiment. Control mice 
reached 20.6 ±0.66 g body weight, whereas the HSD group had 22% higher body weight 
with 25.2 ±0.42 g (Fig. 37c). 
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Fig. 37 Energy intake and body weights in C57BL/6J mice during prolonged control or HSD 
feeding. Mice at 4 weeks of age were caged singly, acclimatised on the control diet for 1 week 
and weaned on either the control diet or the HSD. Daily energy intake was calculated based on 
dietary composition (a). Mean daily energy intake was calculated over the six-week dietary 
intervention (b). Body weights were measured weekly and means are given (c).  Data presented 
are means ± SEM (n = 8). Statistical significance was established with a Student’s t-test or one-
way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant. 
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4.5.2 High-sucrose diet: Macronutrient intake 
The high preference and consumption of LCM changed the macronutrient 
intake in both groups. Mice in the HSD group had significantly higher intake of 
carbohydrates, especially sucrose and lactose, but significantly lower intake of protein 
(Fig. 38). Fat consumption was below 1% of total energy intake and no change was 
observed between control and HSD mice. HSD mice derived 62% of their total caloric 
intake from sucrose, compared to only 11% in the control group (P < 0.001).  
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Fig. 38 Macronutrient intake of C57BL/6J mice during prolonged HSD or control feeding. 
Macronutrients were calculated from the mean daily food intake (pellet and LCM) based on the 
composition information outlined in methods section 4.4.1. Data are presented as means ± SEM 
(n = 8).  Statistical significance was tested with a Student’s t-test. *P < 0.05, **P < 0.01, ***P < 
0.001, ns = not significant. 
 
  
Chapter 4: Effects of high-sucrose feeding on nutrient sensing in the alimentary tract 
 
- 137 - 
4.5.3 High-sucrose diet: Blood analysis 
Not only does the high intake of carbohydrates, especially the simple 
disaccharides lactose and sucrose, led to higher body weights, but biochemical analysis 
displayed mean fasting glucose levels of 11.89 mMol/L in HSD mice compared to 5.23 
mMol/L for control mice (Fig. 39). HSD mice were not hyperinsulinemic, but had 
increased mean serum cholesterol levels (2.08 vs 1.82 mMol/L, p=0.06 HSD vs control). 
Serum triglyceride and non-esterified fatty acids (NEFA) were decreased between 
groups. Serum triglycerides levels decreased from 0.71 to 0.48 mMol/L (P < 0.05) and 
NEFA levels from 1.50 to 0.85 mMol/L (P < 0.05) in HSD mice. 






















































































Fig. 39 Blood serum analysis for metabolic biomarkers of C57BL/6J mice during prolonged HSD 
or control feeding. Levels were measured from blood serum as outlined in methods section 4.4.2 
and data are presented as means ± SEM (n = 8). Statistical significance was tested with a 
Student’s t-test. *P < 0.05, ns = not significant.   
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4.5.4 Nutrient-sensor, gut-peptide and iNOS expression in the 
alimentary tract of mice on a high-sucrose diet 
We used microarrays to study gene-expression profiles in the small intestine 
after six weeks of high-sucrose feeding. We manually extracted taste- and nutrient-
sensing genes including fat-, umami-, sour- and bitter-taste genes, as well as 
downstream signalling molecules, from the microarray. Only very little change for sweet, 
umami, sour and bitter receptors, as well as αGustducin and αTransducin, was found 
(see Fig. 40).  
 
Fig. 40 Fold changes of regulated nutrient-sensor genes in the small intestine of HSD-fed mice. 
RNA was pooled from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA 
expression was compared between Ctrl and HSD mice and fold changes are given.  
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CD36 was downregulated in all three tissues studied, but the highest regulation 
was in the proximal regions (-4.62x in the duodenum and -3.12x in the jejunum) 
compared to a downregulation of only -1.41 in the ileum. This cephalocaudal pattern 
corresponded to the signalling genes trpm5 and plcb2, which were only upregulated in 
the proximal regions of HSD-fed mice (Fig. 40). 
Interestingly, we also found high regulation of the SGLT3 sensor/transporter 
genes with the same pattern cranial to caudal. SGLT3a and SGLT3b were downregulated 
-2.61- and -4.23-fold in the duodenum, but only -1.73- and -3-fold in the jejunum and 
were barely regulated in the ileum (Fig. 40). 
We were able to confirm the microarray findings via qPCR. While T1R2 showed 
no regulation in all tissues, T1R3 showed downregulation by 28% (P<0.05) and 27% 
(P=0.08) in the jejunum and ileum (Fig. 41a+b). SGLT3a and SGLT3b were both 
downregulated in the duodenum and jejunum, as indicated by the microarray (Fig. 
41c+d). Furthermore, the fat receptor CD36 was highly downregulated in both the 
duodenum (-80%) and the jejunum (-64%), but was not regulated in the tongue, 
stomach or ileum (Fig. 41e). 
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Fig. 41 Gene-expression change of nutrient receptors in the alimentary tract of mice fed a HSD. 
Whole tongue, stomach, duodenum, jejunum and ileum were dissected from C57BL/6 fed either 
the HSD or the control diet. RNA was extracted for subsequent quantitative PCR of the sweet-
taste receptor subunits a) tas1r2 (T1R2) b) tas1r3 (T1R3), c) slc5a4a (SGLT3a), d) slc5a4b 
(SGLT3b) and e) cd36b (CD36). Values are normalised against 3 reference genes, relative 
quantitation was performed using the ddCT method and expressed relative to the control diet. *P 
< 0.05, **P < 0.01, ***P < 0.001, ns = not significant, nd = not detected. 
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As nutrient sensor can regulate gut peptide secretion, we analysed the gene 
expression of CCK, ghrelin and preproglucagon. CCK expression was significantly 
upregulated by 65% in the jejunum of HSD mice (Fig. 42a). Ghrelin showed a 4-fold 
induction in the stomach (Fig. 42b), but did not reach statistical significance (p=0.13). 
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Fig. 42 Gene-expression change of gut peptides in the gastrointestinal tract of mice fed a HSD. 
Whole stomach, duodenum, jejunum and ileum were dissected from C57BL/6 fed either the HSD 
or the control diet. RNA was extracted for subsequent quantitative PCR of the gut peptides a) cck 
(CCK) b) ghrl (ghrelin) and c) gcg (preproglucagon). Values are normalised against 3 reference 
genes, relative quantitation was performed using the ddCT method and expressed relative to the 
control diet. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant. 
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Our array data showed an upregulation in the duodenum. As NO signalling has 
been implicated in pancreatic dysfunction, lingual taste-signal transduction and gastric 
tufted cell signalling, we hypothesised that iNOS could also be an important signalling 
molecule in EECs and that the expression of nos2 is also upregulated along the 
alimentary tract of HSD-fed mice. Indeed, nos2 was highly induced in the tongue and 
small intestine of HSD mice compared to control animals (Fig. 43). nos2 was upregulated 
7-fold in the tongue, 34-fold in the duodenum, 6-fold in the jejunum and 4-fold in the 
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Fig. 43 Gene-expression change of iNOS/nos2 in the alimentary tract of mice fed a HSD. Whole 
tongue, stomach, duodenum, jejunum and ileum were dissected from C57BL/6 fed either the 
HSD or the control diet. RNA was extracted for subsequent quantitative PCR of nos2 (iNOS). 
Values are normalised against 3 reference genes, relative quantitation was performed using the 
ddCT method and expressed relative to the control diet. *P < 0.05, **P < 0.01, ***P < 0.001, ns = 
not significant. 
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4.5.5 Gene-expression profiling of the small intestine of high-sucrose 
fed mice 
4.5.5.1 Enrichment analysis 
We further used the microarray data to compare the expression profiles of the 
duodenum, jejunum and ileum, which revealed 81 common and 297 similar genes 
affected by the dietary intervention. Yet 408, 369 and 403 genes were uniquely 
regulated in the duodenum, jejunum and ileum respectively (Fig. 44). 
 
 
Fig. 44 Unique, similar and common genes regulated in the HSD model between the 
duodenum, jejunum and ileum. 
Enrichment analysis revealed that common pathway maps, GO processes and 
networks were related to either cell cycle (mitosis, replication, transcription), immune 
response (antiviral, B-cell receptor, interferon signalling) or regulation of metabolism 
(progesterone signalling, retinol metabolism, bile-acid regulation) (see appendix II). 
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4.5.5.2 Top 10 regulated genes 
We manually extracted the top 10 up- and downregulated genes in all three 
tissues. On the one hand it confirmed the high regulation of immune-system genes 
(reg2, fut2, reg3d, susd2, anxa10, nos2), but it also revealed novel genes to be regulated 
by the diet. Genes regulated in the duodenum were involved in Golgi glycosylation 
(mgat4c, b3galt5, fut2), NADPH/ROS metabolism (duoxa2, cubn), Cytochrome 
superfamily (cyp2c38, cyp3a44, cybrd1), gluconeogenesis (pck1), Calcium channel 
(trpbv), lactate/acetate (slc5a12) or Vitamin C (slc23a1) absorption and 
neurotransmission (nos2) (Fig. 45). Especially of interest is the 4-fold downregulation of 
the novel sugar sensor slc5a4b/SGLT3b and the fat sensor cd36/CD36 (Fig. 45). 
 
Fig. 45 Fold changes of the top ±10 HSD regulated genes in the murine duodenum. RNA was 
pooled from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA expression 
was compared between Ctrl and HSD and fold changes are given. 
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An overlap of certain genes between the duodenum and the jejunum was 
noticed (duoxa2, b3galt5 susd2) (Fig. 46), and a majority of genes, mainly upregulated, 
were also involved in immune function (ifi44, ms4a1, ccl20, bank1, sell, h20-ob, susd2, 
plb1) or in the Cytochrome superfamily (cyp2c38, cyp4a31, cyp4a10). Highly regulated 
was the gene encoding phospholipase B1 plb1, with an 87-fold downregulation. Two 
genes were involved in ketone/lipid metabolism (oxct1, ces1), nt5e is a nucleotidase 
converting extracellular nucleotides to membrane-permeable nucleosides, bpm9 is 
involved in cell maturation, especially of cholinergic neurons and ddah1 is involved in 
generating nitric oxide by regulating cellular concentrations of methylarginines, which in 
turn inhibits nitric oxide synthase activity (Fig. 46). 
 
Fig. 46 Fold changes of the top ±10 HSD regulated genes in the murine jejunum. RNA was 
pooled from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA expression 
was compared between Ctrl and HSD and fold changes are given. 
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In the ileum, too, a high induction of immune genes was noticed, especially 
interferon-signalling genes (ifi44, ifi1, herc5, ddx60) and genes belonging to the 
gasdermin family (gsdmc4, gsdmc3, and gsdmc2) were downregulated, whereas B-
Lymphocyte genes cd19 and ms4a1 were down (Fig. 47). Also regulated were genes 
involved in lipid metabolism (adipoq, lpl, scd1), imino-acid transport (slc6a20b), histone 
acetylation (hist1h2ab) and a carbonic anhydrase (car5b) (Fig. 47). 
 
Fig. 47 Fold changes of the top ±10 HSD regulated genes in the murine ileum. RNA was pooled 
from 8 mice per group and analysed on an Affymetrix microarray chip. mRNA expression was 
compared between Ctrl and HSD and fold changes are given. 
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4.5.6 Effects of chronic sucrose exposure in an enterocyte in vitro 
model, Caco-2/TC7 cells  
Our gene-expression studies in high-sucrose fed animals revealed a 
downregulation of slc5a4/SGLT3 in the small intestine. Furthermore, we detected an 
induction of nos2 in the tongue and small intestine and a downregulation of ddah1 in 
the small intestine, both involved in NO production. Yet we do not know if the sucrose is 
causative for the gene down-regulation, in which cell-types these genes are 
downregulated and if the higher expression of iNOS leads to higher NO levels. We 
hypothesised that the higher activity of iNOS in enterocytes leads to NO generation and 
in turn downregulation of slc5a4 and cd36. 
We therefore used Caco-2/TC7 cells as a model for intestinal epithelium. To test 
if Caco-2/TC7 cells express SGLT3, we performed RT-qPCR for SGLT1 (slc5a1), SGLT3 
(slc5a4) and CD36 (cd36) in differentiating Caco-2/TC7 cells at day 5, 10 and 21. As 
expected, SGLT1 expression is increased during the differentiation of the Caco-2/TC7 
cells and 73x higher at day 21 compared to day 5 (Fig. 48a). SGLT3 shows a similar, 
pattern with mRNA expression increasing 29-fold on day 21 (Fig. 48b). CD36 was not 
expressed (data not shown). 
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Fig. 48 SGLT1 and SGLT3 mRNA expression time-course in Caco-2/TC7 cells. RT-qPCR was 
performed on 6 samples on day 5, 10 or 21 and normalised against βActin expression. Values are 
expressed relative to day 5. 
62% of the energy intake in the HSD group is from sucrose. We therefore 
stimulated differentiated Caco-2/TC7 cells for three days with 25 mM sucrose or D-Glu 
to compare expression levels of SGLT1, SGLT3 and iNOS and also measured NO 
produced by the cells. Sucrose stimulation did not increase gene expression for 
slc5a1/SGLT1, slc5a4/SGLT3 or nos2/iNOS (Fig. 49a). Nitric oxide in cell media was 
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Fig. 49 Effect of 3-day sucrose feeding of Caco-2 cells on gene expression and nitric oxide 
secretion. Differentiated, 18-day-old Caco-2/TC7 cells were maintained in either 25 mM D-Glu 
(white bars) or sucrose (dark bars). After 3 days cells were harvested either for RNA extraction 
and RT-qPCR (a) or nitric oxide measurements from media (b). ns = not significant.  
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4.6 Discussion 
At the heart of metabolic syndrome, obesity and type 2 diabetes lies the 
overconsumption of foods. Carbohydrate intake in the form of added sugars in foods 
and SSB has significantly increased in recent decades, and it has been suggested that this 
increase is one of the factors responsible for the obesity epidemic. The gastrointestinal 
tract has been established as an important endocrine organ and regulator of metabolism 
and its role in the pathophysiology of metabolic syndrome is gaining more importance. 
Only few studies have examined whether gastrointestinal nutrient sensing and gut 
peptides are dysregulated in metabolic syndrome and mainly focus on the stomach 
(Young et al., 2009; Widmayer et al., 2012; Ritze et al., 2014; Widmayer et al., 2015). We 
therefore aimed to evaluate how a diabetogenic diet high in added sugars changes the 
function of the alimentary tract with special focus on nutrient-sensor expression levels. 
4.6.1 Metabolic observations, nutrient sensing & gut peptides 
To induce metabolic syndrome in our study we used fat-reduced condensed 
milk, which combines several things: 1) a preferred concentration of sugar and 
sweetness, 2) high energy density, 3) a soft and preferred texture and 4) constant 
accessibility. The high reward and palatability led to increased food intake, which in turn 
led to higher energy intake and the slow accumulation of body weight as demonstrated. 
Metabolic profiling on fasting blood revealed that HSD mice were diabetic, characterised 
by fasting hyperglycaemia and hypercholesterolemia. Our study adds to the pool of 
studies associating high sugar intake with effects on metabolic health. 
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The macronutrient analysis of the diet revealed that the HSD group not only has 
higher intake of carbohydrates but also shows a switch from starch to the simple, 
refined sugars sucrose and lactose. Many studies in rodents have been conducted 
comparing complex and simple carbohydrates on body-fat accumulation. Sucrose-rich 
pellet chow can induce body-fat gain in some contexts when compared to starch (Reiser 
& Hallfrisch, 1977; Hallfrisch et al., 1979; Toida et al., 1996). In some cases, though, 
sugar actually leads to similar or less body-weight increases than starch (Gutman et al., 
1987; Surwit et al., 1995; Black et al., 1998; Cresci et al., 1999). A potential reason for 
the varied results is the concentration of sugars in the test diets, as too low or too high a 
concentration has been shown to change the taste preference and a ‘sweet spot’ at 
~25% sugar in water has been established (Richter & Campbell, 1940). Adding sugar to 
drinking water is actually another very effective way to fatten animals. Offering animals 
sweet sugar rich liquids consistently causes body-fat accumulation (Kanarek & Orthen-
Gambill, 1982; Young et al., 2009).  
4.6.2 Nutrient-sensor & gut-peptide expression 
The metabolic observations led us to hypothesise that the metabolic 
dysregulations were due to disturbances in the small intestine, especially of nutrient-
sensing mechanisms and gut-peptide secretion. The analysis of the nutrient-sensor 
expression levels revealed some novel and interesting findings. Although T1R2 and T1R3 
were not regulated in any of the tissues studied, strong downregulations were found for 
CD36 and SGLT3a+b in the intestine. All three sensors were more downregulated in the 
duodenum and jejunum than in the ileum. This is interesting, as the proximal intestine is 
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where luminal nutrient concentrations are highest. Furthermore, CCK expression was 
increased in the jejunum and ghrelin was highly induced in the stomach, which is in line 
with other studies (Ritze et al., 2014; Widmayer et al., 2015).  
These adaptions could be part of a response mechanism adjusting the 
gastrointestinal system to the constant energy and sugar surplus. It is plausible that such 
a downregulation of SGLT3a+b expression in the small intestine might be due to 
desensitisation of the cells as a consequence of a sustained access to sucrose and its 
breakdown products. Yet the fact that SGLT3, expressed in the enteric nervous system, 
is downregulated could have several effects. Meal-induced ghrelin suppression relies on 
a small-intestinal nutrient sensor. Indeed, we measured higher expression of ghrelin in 
the stomach in HSD mice. This could be a potential explanation for the overeating of the 
animals. Furthermore, the enteric nervous system is involved in the incretin response. It 
is possible that the pancreas is less stimulated to secrete insulin in our model, which 
could explain the high fasting-glucose levels measured. Lastly, gastrointestinal nerves 
are crucial in the translation of signals from the intestine in terms of control of food 
intake. Downregulated SGLT3 could mean fewer signals to satiety centres in the brain, 
which could explain the demonstrated hyperphagia. Interestingly, SGLT3 has been 
suggested as a portal vein glucose sensor important for the crosstalk between the 
periphery and the hypothalamus to regulate meal size and duration  (Delaere et al., 
2013; Mithieux, 2014).  
The upregulation of CCK is interesting and could be explained by the fact that it 
stimulates pancreatic insulin secretion, which is important for controlling the 
hyperglycaemia observed in the HSD animals. GLP1 did not show a change in gene 
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expression, but GLP1 with its short half-life could be more important for the short-term 
regulation of postprandial blood glucose, whereas CCK is more important in the long 
term. 
4.6.3 Nitric oxide 
NO is a widely used molecule in the body, including the alimentary tract (Lane & 
Gross, 1999; Keklikoglu et al., 2008) and is involved in feeding, taste-cell  and   EEC 
signalling, but has also been implicated in pancreatic dysfunction. We hypothesised that 
NO is involved in lingual and gastrointestinal chemosensory cells as a signalling-molecule 
and therefore analysed the expression of nos2 in the alimentary tract of HSD mice. 
We measured a strong induction of nos2 expression and identified ddah1 
expression to be downregulated in the tongue. Nos2 produces NO, whereas ddha1 
regulates cellular concentrations of methylarginines, which in turn inhibits NOS activity. 
Taken together, these observations could lead to higher production of NO. As the 
condensed milk used in the HSD is highly palatable and sweet, this could potentially 
mean that taste reception and signalling to the brain in the HSD model is increased via 
NO in taste papillae and hence could be involved in the observed hyperphagia. 
nos2 was also highly induced in the small intestine, especially in the duodenum. 
Since SGLT3 levels were decreased, the high nos2 expression could be explained as a 
compensatory mechanism to overcome the decreased SGLT3 mediated signalling to the 
brain. Furthermore, an interesting study found that CCK secretion is iNOS/NO 
dependent (West et al., 2003). We speculate that the higher expression of cck in our 
model is caused by an upregulation of nos2. It would therefore be interesting to study 
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sucrose-dependent gut-peptide secretion in EEC in vitro models to measure direct 
effects and establish whether iNOS/NO is part of the signalling cascade, in order to 
confirm a functional link between our CCK and iNOS gene-expression data.  
We emulated the HSD model in vitro by chronically feeding Caco-2/TC7 cells 
with sucrose, in order to study the effects on slc5a4 and nos2 expression as well as NO 
production. It has been suggested that enterocytes directly sense nutrients to regulate 
cellular gene expression such as sugar transporters. We hypothesised that the high 
luminal sucrose levels led to NO mediated downregulation of SGLT3 expression directly 
in enterocytes. Although sucrose feeding did not change gene levels for iNOS or SGLT3 in 
Caco-2/TC7 cells, NO levels were increased although not significant. This suggests 
sucrose is not an agonist for SGLT3 or SGLT3’s role in vivo is not on enterocytes. 
Furthermore, we speculate, also in regard to our in vivo findings regarding CCK, that the 
measured NO produced in enterocytes is used as a paracrine signal for gut peptide 
secretion from neighbouring EECs. These findings suggest further research to identify 
the target of NO, and also the exact process it is involved in.  
Yet NO is also involved in many processes, such as smooth-muscle cell-
relaxation, that can lead to vasodilation. A potential function in the intestine of our HSD 
model could be to directly relax the smooth muscle cells in the intestinal wall. This in 
turn reduces motility and increases transfer times of the chyme ultimately enabling 
greater nutrient absorption. A pattern favourable in times of scarcity maximising 
nutrient intake, this could mean a potential maladaptation to the ad libitum food 
availability in the HSD model. 
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Another role of NO is in the immune system. Not only can NO lead to 
vasodilation to slow blood flow to enable easier tissue infiltration by immune cells, but 
phagocytes are also equipped with iNOS for various different functions (e.g. T-cell 
maturation, B-cell proliferation, induction of apoptosis) (Bogdan, 2001). Gene-
expression profiles generated using microarrays revealed several interesting 
observations. Enrichment analysis and top 10 gene evaluation for GO processes and 
pathways revealed the highest genes regulated were involved either in cell cycle, 
metabolic regulation or immunity. The high regulation of immune-function genes is in 
line with the systemic and chronic inflammatory state observed in metabolic syndrome. 
Furthermore, it has been shown how a high-fat diet induces inflammatory proteins in 
the small intestine of mice (Ding et al., 2010). This was due to diet-induced dysbiosis of 
the gut flora and it has been suggested that intestinal inflammation then leads to 
epithelial hyperpermeability and endotoxemia, which induces systemic inflammation 
leading to the onset of insulin resistance (Moreira et al., 2012). Interestingly, the 
intestinal component of this cascade is present and measurable before the onset of 
obesity or diabetes (Ding et al., 2010). A link between local intestinal inflammation and 
insulin-resistance of enterocytes has also been established (Monteiro-Sepulveda et al., 
2015). Insulin internalises apical GLUT2 in healthy, but not diabetic mice, which can lead 
to uncontrolled energy absorption and metabolic disorders (Tobin et al., 2008). This puts 
the gastrointestinal tract at the centre of metabolic deregulations and not just a tissue 
affected by systemic inflammation. 
The local inflammation we found may also explain the high regulation of cell 
cycle/replication-related genes. As we have crude intestinal tissue, this could mean 
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several cell types. Intestinal stem cells could be induced to proliferate to counteract the 
epithelial damage and immune cells multiply to defend it, are both plausible 
explanations. 
We analysed macrophage markers in the microarray, but did not find any 
change of expression (data not shown). This suggests that the location of the 
upregulated nos2 is not in macrophages, but could indeed be in the endothelium, 
enterocytes or EECs, as discussed above. It would be of interest to study the effects of 
inflammation on nutrient sensors in in vitro models for these cell types. 
Interestingly, it has been shown that CCK can inhibit inflammation via the vagus 
nerve upon nutrient stimulation (Luyer et al., 2005). CCK has also been shown to play a 
role in gastric mucosal defence systems after damage from irritants (West et al., 2003). 
CCK could hence be upregulated in our model to counteract any damage caused by a 
dysregulated microbiota. 
4.6.4 Metabolic regulation 
Furthermore, high regulation of genes involved in ‘metabolic regulation’ was 
detected, including bile-acid-regulating genes. A link between the microbiome, bile acids 
and metabolism has been established. Bile acids are highly metabolised by gut bacteria 
and have been shown to regulate intestinal homeostasis (Jones et al., 2014; Brandsma & 
Houben, 2015). They are recognised as ligands in a wide range of metabolic processes 
including the Farnesoid X receptor (FXR) and also the bile-acid-responsive G protein-
coupled receptor 5 (TGR5) on L-cells, where it is involved in GLP1 secretion (De Aguiar 
Vallim et al., 2013). 
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Manual extraction of the top 10 regulated genes revealed another set of genes 
regulated in the HSD model. A similar picture regarding the high regulation of immunity 
genes was found, especially the interferon and gasdermin family. Furthermore, several 
members of the cytochrome P450 family were downregulated, notably cyp4a10 and 
cyp4a31. Involved in fatty-acid oxidation and eicosanoid formation, cyp4a10 has been 
shown to be downregulated after fasting (Van den Bosch et al., 2007). Several other 
genes involved in lipid metabolism were also regulated. Since the fat intake in both 
dietary groups was below 1%, but unchanged between groups, this poses the questions 
of why these genes are dysregulated and how they are involved in metabolism. Studies 
in hepatocytes and skeletal muscles have shown how high amounts of added sugars 
can increase glycolytic flux, which directly reduces fatty-acid oxidation (Coyle et al., 
1997; Cox et al., 2012). We therefore suggest that as the added sugars are digested 
and assimilated by the gastrointestinal tract intestinal glycolytic flux increases, which 
in the long term leads to a suppression in genes necessary for fatty-acid oxidation. 
Potentially this phenomenon is also involved in the measured downregulation of 
CD36 gene expression in the HSD-fed mice. 
In the ileum of HSD-fed mice slc6a14 was highly regulated, with a 6-fold 
induction. This solute carrier was not regulated in the proximal regions. Slc6a14 is 
interesting, as it encodes an alanine transporter, which potentially regulates tryptophan 
availability for serotonin synthesis. A very strong association of obesity with a single 
nucleotide polymorphism (SNP) in slc6a14 has been shown in a Finnish cohort 
(Suviolahti et al., 2003; Cheung & Mao, 2012). Interestingly, serotonin or 5-
hydroxytryptamine (5-HT) has been found to be involved in gastric emptying by 
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targeting 5-HT3 receptors on duodenal vagal efferents (Raybould et al., 2003). 
Furthermore, 5-HT antagonists have been shown to reduce the anorexigenic effect of 
carbohydrates in the intestine (Savastano et al., 2005). 5-HT is highly expressed in 
αGustducin- and GLP1-positive cells (Sutherland et al., 2007) and vagal afferents have 
been reported to have increased responsiveness to 5-HT in an inflammatory state 
(Coldwell et al., 2007). 5-HT is potentially a co-signal to GLP1 initiating satiation after 
carbohydrate ingestion (Sutherland, 2008). There could be a potential link between 
slc6a14-expressing EECs and SGLT3-expressing neurons. If slc6a14 expression and hence 
5-HT production is higher in EECs, vagal afferents are more stimulated, which could 
reduce SGLT3 expression as detected in our model. Further research is needed to 
elucidate links and exact mechanisms. 
4.7 Limitations of the study 
Our results indicate a clear dysregulation of the chemosensory pathways and 
gut peptides. Yet these observations are just associations and we do not know if 
dysregulated nutrient sensors/gut peptides are causative for the phenotype; this 
requires further research. Pair-feeding would enable us to study the effects of the 
dietary composition independent of the calories consumed (Ellacott et al., 2010). 
Furthermore, a shorter feeding experiment would allow us to study if the observed 
changes are already present before the onset of type 2 diabetes 
It would also be of high interest to measure blood gut peptide levels and 
determine exact locations/cell populations of affected genes, as we used crude tissue 
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samples for our analysis. Furthermore, it would valuable to confirm transcriptomic 
findings on a proteomic level. 
In our study crude intestinal tissue was used. Using mucosal scrapings or in situ 
experiments would have been highly beneficial in order to identify locations of gene 
changes such as enterocytes, EECs, neurons or smooth muscle cells. 
Furthermore, it has been shown that shifting circadian rhythms in mice induces 
gastrointestinal, metabolic and immune alterations that are influenced by the core clock 
machinery and ghrelin (Laermans et al., 2014). It would be of interest to study how the 
HSD affects the core clock machinery and the diurnal rhythmicity of the studied sensors. 
The intestinal tract is highly studied regarding its microbiota and how diet can 
affect the microbial colonies and even lead to disease (Ramakrishna, 2013). Microbiotic 
profiling with genetic techniques would help to determine exact subpopulations and 
possibly to identify a switch to a pathogenic profile. 
4.8 Conclusions 
In conclusion, our findings suggest an association between high-sucrose feeding 
and dysregulation of nutrient sensors and induction of gut peptide and iNOS expression. 
Many more systems including inflammation, bile-acid secretion and serotonin 
signalling, processes highly involved in metabolism, were identified to be affected by the 
sugar-rich diet. More in-depth research will be needed to fully understand the processes 
involved and could eventually lead to a better understanding of the physiology and 
potential targets for therapy of metabolic syndrome. 
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5 GENERAL CONCLUSION & FUTURE STUDIES 
5.1 Conclusion  
Nutrient sensors in the alimentary tract, in particular sugar sensors, have been 
implicated in the regulation of feeding and metabolism. Disruptions of such systems are 
hence potentially involved in the pathology of metabolic diseases. The purpose of this 
thesis was to study the short-term regulation of sugar transport by the sweet-taste 
receptor using an in vitro enterocyte model, as well as to evaluate nutrient-sensing 
mechanisms in the long-term under healthy and diseased conditions. 
We were able to demonstrate that in the short term the enterocyte in vitro 
model, Caco-2/TC7 cells, was able to respond to changes in external sugar substrate 
concentrations (D-Glu or HFCS) with higher transport capacities for D-Glu and Fru. Cells 
were not responsive to higher Fru or sucrose concentrations. Yet we showed that the 
displayed upregulation of transport was not mediated via the sweet-taste receptor, as 
artificial sweeteners or an inhibitor did not change transport activity. We speculated 
that another sensor could be responsible for our observations and the long-term studies 
revealed a dietary regulation of SGLT3. We therefore chronically exposed Caco-2/TC7 
cells to sucrose, but did not measure any regulation of SGLT3 gene expression. We 
confirmed that SGLT3 is not involved by using parental Caco-2 cells, which do not 
express SGLT3, but demonstrated similar results regarding the D-Glu mediated short-
term stimulation of D-Glu and Fru transport by D-Glu as outlined in chapter 2 (data not 
shown). In conclusion regarding Caco-2/TC7 cells, neither the sweet-taste receptor nor 
SGLT3 seem to be involved in regulating transport activities upon external sugar load 
and suspect another sensor/sensing mechanism to be involved. Cellular mechanisms 
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such as increased vesicle transport or higher amounts of cellular ATP after sugar influx 
could also lead to transactivation of hexose transporters. Indeed Na+/K+-ATPase activity 
has been shown to be increased in enterocytes of diabetic rats which also had increased 
brush-border GLUT2 and GLUT5 expression (Corpe et al., 1996). Taken together, these 
findings are especially interesting in regard to the direct model of sugar sensing as it 
would not require a specified membrane-bound sensor. 
The long-term, high-sucrose feeding of mice revealed that it not only leads to 
type 2 diabetes, but that SGLT3 was highly downregulated, which suggests SGLT3 is 
under dietary regulation. Luminal nutrient loads change throughout the day and are 
synchronised to gastrointestinal nutrient absorption and gut peptide secretory 
mechanisms. SGLT3 also displayed diurnal rhythmicity supporting the fact that it is 
under dietary control. 
SGLT3 is expressed in various tissues involved in metabolism including the 
hypothalamus, kidney, liver, intestinal mucosa and enteric nervous system. Studies have 
shown how SGLT3 is involved in nutrient sensing related mechanisms such as GLP1 
secretion and portal vein sensing, but that it is highly specific to D-Glu (Diez-Sampedro 
et al., 2003). It is likely that in the small intestine SGLT3 is either involved in EEC nutrient 
sensing or has a intraepithelial function (e.g. on cholinergic neurons) where sucrose has 
been broken down to D-Glu and Fru and then absorbed.  
Taken together, the dietary regulation of SGLT3 suggests that it might be 
important in diet-related disease. This recommends future studies to determine exact 
location and function of the protein and if the dysregulated SGLT3 expression is causal 
or consequential to metabolic disease.  
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5.2 Future studies 
As SGLT3 was dysregulated in metabolic syndrome and displayed diurnal 
rhythmicity, several questions opened up demanding further research. First, it needs to 
be demonstrated that SGLT3 has a clear circadian oscillatory expression-pattern at the 
mRNA and protein levels and is under the transcriptional control of clock genes. Once 
this is established it would be of interest to study if the circadian rhythmicity of SGLT3 is 
attenuated in metabolic syndrome and if this is causative for the metabolic 
disturbances. Using more time-points might also reveal diurnal rhythms for the sweet-
taste receptor and other studied genes. Furthermore, it is not clear in which cell type 
the regulation of SGLT3 occurs and in situ expression studies would allow to determine if 
the changes indeed appear in cholinergic neurons or in mucosal cells such as EECs or 
enterocytes. As we also showed higher iNOS expression it would be of strong interest to 
identify in which cells this occurs and which mechanism the potential higher amounts of 
NO are involved in. As SGLT3 has been implicated in portal vein sensing (Delaere et al., 
2013), it would be interesting to also study if these mechanisms are disturbed in the HSD 
model. Furthermore, it would be of high interest to use in vitro models of EECs to study 
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APPENDIX I: ENRICHMENT ANALYSIS OF THE MICROARRAY ON TONGUE RNA AT 7AM 
VS 7PM PRESENTED IN CHAPTER 3 
We applied the GeneGo MetaCore™ software package and identified the top 10 
regulated pathways in the tongues of mice at 7am vs 7pm with an enrichment analysis 
(Fig. 50). The strongest pathways enriched in our experiment are cytoskeletal 
arrangement, cell adhesion and cell differentiation/ development mediated via Wnt 
signalling, but also immunity processes. 
 
Fig. 50 Microarray data analysis for top 10 diurnally regulated pathways in the tongue. 
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We enriched our data set for gene onthology (GO) processes (Fig. 51a) and 
process networks (Fig. 51b) and confirmed that mainly cellular organisation, 
development and signal transduction are regulated in the tongue, but also inflammatory 
networks. 
 
Fig. 51 Microarray analysis for top 10 Gene ontology and process networks. Fold changes were 
enriched for GO processes (a) or process networks (b) in the GeneGo® software package. 
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APPENDIX II: ENRICHMENT ANALYSIS OF THE MICROARRAY ON THE SMALL 
INTESTINE OF HSD MICE PRESENTED IN CHAPTER 4 
We applied the GeneGo MetaCore™ software package to enrich expression 
profiles for pathways, networks and processes regulated in the duo, jej and ile of HSD 
mice. The strongest common pathway maps, GO processes and networks regulated in 
our experiment were related to either cell cycle (mitosis, replication, transcription), 
immune response (antiviral, B-cell receptor, interferon signalling) or regulation of 
metabolism (progesterone signalling, retinol metabolism, bile acid regulation) (see Fig. 
52, Fig. 53 and Fig. 54) 
 
Fig. 52 Microarray data analysis for the top 10 regulated pathways in the small intestines of 
HSD mice. Common pathways between the Duo, Jej and Ile are displayed as blue/white hatched 
bars. Significances for individual tissues compared to the Duo are displayed as blue for the Jej and 
yellow for the Ile. Enrichment analysis for pathway maps in the GeneGo® software. 
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Fig. 53 Microarray data analysis for the top 10 regulated GO processes in the small intestines of 
HSD mice. Common GO processes between the Duo, Jej and Ile are displayed as blue/white 
hatched bars. Significances for individual tissues compared to the Duo are displayed as blue for 
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Fig. 54 Microarray data analysis for the top 10 regulated networks in the small intestines of 
HSD mice. Common networks between the Duo, Jej and Ile are displayed as blue/white hatched 
bars. Significances for individual tissues compared to the Duo are displayed as blue for the Jej and 
yellow for the Ile. Enrichment analysis for GO processes in the GeneGo® software. 
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